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ABSTRACT 
 
 
 
MCNP Modeling of Prostate Brachytherapy and Organ Dosimetry. (May 2003) 
 
Susrut Rajanikant Usgaonker, 
 
B.S., Texas A&M University 
 
Chair of Advisory Committee: Dr. John W. Poston Sr. 
 
 
 Using the computer code Monte Carlo N-Particle (MCNP), doses were calculated 
for organs of interest such as the large intestine, urinary bladder, testes, and kidneys 
while patients were undergoing prostate brachytherapy.  This research is important 
because the doses delivered to the prostate are extremely high and the organs near the 
prostate are potentially at risk for receiving high doses of radiation, leading to increased 
probabilities of adverse health effects such as cancer.  In this research, two MCNP 
version 4C codes were used to calculate the imparted energies to the organs of interest 
delivered by 125I and 103Pd.  As expected, the organs nearest to the prostate received the 
highest energy depositions and the organs farthest from the prostate received the lowest 
energy depositions.  Once the energy depositions were calculated, the doses to the 
organs were calculated using the known volumes and densities of the organs.  Finally, 
the doses to the organs over an infinite time period were calculated. 
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CHAPTER I 
 INTRODUCTION. 
OBJECTIVES 
 The objective of this research was to determine the radiation-absorbed doses to 
the organs that were likely to receive significant doses from the implantation of 
radioactive brachytherapy seeds in the prostate.  This was achieved by using computer 
codes that were executed with Monte Carlo N-Particle (MCNP) to calculate the doses to 
the organs of interest (Briesmeister 2000). 
BENEFITS VS. RISKS 
 For many decades, radiation has been beneficial in both diagnostic and 
therapeutic nuclear medicine.  Radiation has been used to diagnose and treat cancer with 
processes such as ablation (as in 131I therapy used to treat thyroid cancer), brachytherapy, 
and external beam therapy.   
One of the most effective radiation therapies is prostate brachytherapy.  
Brachytherapy has been a successful mode of treatment for prostate cancer for years.  
Although other options such as surgery and external beam therapy exist, brachytherapy 
has been the best at preventing reoccurring tumors. Prostate brachytherapy involves the 
permanent placement in the prostate gland of radioactive seeds, which emit energetic 
particles through radioactive decay by modes of electron capture and emission of 
photons.  These energetic particles irradiate the internal tissues of the prostate, 
                                                 
This thesis follows the style and format of Health Physics. 
 
1 Personal Communication: Dr. George Warner, May 2002. 
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diminishing the volume of the tumor and killing the cancer cells, preventing them from 
reoccurring1.   
The seeds used in prostate brachytherapy are iodine-125 (125I) and palladium-103 
(103Pd).  These two radionuclides have relatively long half-lives compared to most 
radiopharmaceuticals: 59.4 days for 125I and 16.99 days for 103Pd (Chart of the Nuclides 
1996).  Both seeds are about the size of rice grains and are about 4.5 mm long and about 
0.8 mm in diameter.  The 125I seeds consist of 0.05 mm thick titanium walls with welded 
ends and silver markers that are surrounded by 125I (Nath, et al. 1995).  The 103Pd seeds 
also consist of 0.05 mm thick titanium walls, but contain lead x-ray markers instead of 
silver markers (Meigooni, et al. 1990). 
The long-term benefit of undergoing this treatment is the minimized probability 
of reoccurring tumors, adding years to the patients’ lives and allowing them to proceed 
with their regular daily activities.  Although there are significant benefits to undergoing 
this therapy, there are also certain issues that must be considered.  These issues include 
side effects and radiation safety.  The focus of this research is to the dose delivered to 
other organs while undergoing this therapy, since the seeds are permanently implanted in 
the gland.  The doses delivered to the prostate are large and can be as high as 145 gray 
(Gy) in typical treatments. 
This research is important because, since the radiation dose to the prostate is 
large, the neighboring organs (i.e., urinary bladder and genitalia) are at risk of receiving 
high radiation doses.  Areas such as the pelvis, kidneys, stomach, lungs, and organs in 
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the lower portions of the trunk of the body, as well as certain organs in the upper 
portions of the trunk, may receive significant doses from the prostate treatment.   
One disadvantage of prostate brachytherapy is that healthy prostate cells are 
killed along with cancerous cells.  As a result of irradiation of the prostate gland, the 
neighboring genitalia and urinary bladder are likely to be damaged.  One potential risk 
for some men is impotence since the radiation penetrates through the prostate and 
irradiates the cells in the testicles, preventing the production of sperm.  Although this 
effect is not desirable, patients give it less consideration when comparing it to the 
importance of living a long and cancer-free life.  Also, the patients generally are older 
men past the age of active procreation. 
SIGNIFICANCE OF THE RESEARCH 
 The significance of this research is that doses to internal organs can be 
determined.  Organs such as the urinary bladder and the genitalia are likely to receive the 
highest doses from the therapy, since they border the prostate gland.  However, many 
consider the benefits of brachytherapy to greatly outweigh the risks of late effects. 
Because of the complexities of using humans to determine doses to internal 
organs from prostate brachytherapy, using the computer code MCNP in modeling the 
energy deposition in the organs from brachytherapy would be appropriate. Doses to the 
internal organs can be determined using an MCNP code, based on actual brachytherapy 
cases. 
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CHAPTER II 
THEORY 
THE PROSTATE GLAND 
 The prostate gland is a partly muscular, partly glandular organ located distal to 
the neck of the urinary bladder and proximal to the penis.  The gland surrounds the 
proximal urethra within the pelvic cavity, dorsal to the symphysis pubis and ventral to 
the deep layer of the triangular ligament, while immediately adjacent to the rectum.  The 
prostate has an ellipsoidal shape and normally is about the size of a chestnut. The 
glandular part of the prostate consists of epithelial follicular pouches.  The prostate has 
arteries originating in the internal pudic, vesicle, and haemorrhoidal areas.  The veins 
form a plexus around the sides and the base of the gland.  The nerves to the prostate 
originate from the pelvis plexus (Gray 1995). 
The prostate is an essential organ in the male reproductive system that produces 
the fluid in semen, which is ejaculated during sexual intercourse and delivers many 
sperm into the female vagina while the penis is erect. The fluid is alkaline to protect the 
sperm from the acidity of the vagina as they travel to the female ovum.  The prostate is 
also an essential organ for the production of male hormones such as androgens (Marieb 
1998).    
PROSTATE CANCER 
 Prostate cancer is the second most common neoplasm in males over the age of 50 
(Handbook of Diseases 2000).  The most common form of prostate cancer is 
adenocarcinoma, with sarcoma rarely occurring.  Most of the tumors originate in the 
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posterior prostate gland, while the rest originate near the urethra. When the prostate 
lesions metastasize, they invade the prostate capsule and spread along the ejaculatory 
ducts between the seminal vesicles or perivesicular fascia (Handbook of Diseases 2000). 
 In men, prostate cancer accounts for about 18% of all cancers.  The incidence of 
prostate cancer is highest in blacks and lowest in the Asian populations.  The symptoms 
of prostate cancer are difficulty in urinating, urine retention, and unexplained cystitis.  
The American Cancer Society recommends that men over the age of 40 receive a yearly 
digital examination.  For men above the age of 50, it is recommended that blood tests be 
performed to detect the prostate specific antigen (PSA).  Biopsies are used to detect 
malignant tumors in the prostate.  Elevated PSA levels may be significant because serum 
phosphatase levels are increased in two-thirds of men with metastatic prostate cancers.  
The treatment options available are radiation, hormone therapy, and surgery.  If these 
options are not effective, many physicians opt for the use of chemotherapy (Handbook 
of Diseases 2000).  
PROSTATE BRACHYTHERAPY  
 Interstitial brachytherapy has received high interest due to the use of ultrasound 
to guide seed implantation, improved radionuclides for dose delivery, excellent 
treatment planning software for dosimetric calculations, and efficient implantations.  
Due to these factors, the use of brachytherapy implants in prostates is expected to 
increase (Vicini, et al. 1999).  According to the American Brachytherapy Society (ABS), 
the dose distributions after implantation often differ from the planned doses before 
implantation.  For this reason, ABS recommends that a postimplant dosimetric 
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assessment be performed so those actual doses to the prostate and adjacent tissues over 
the treatment period can be documented.  Using these dosimetry results, physicians can 
assess and modify implantation techniques and compare results with other institutions as 
quality assurance for clinical trials (Nag, et al. 2000).   
A drawback to this treatment is the need for customized treatments for different 
patients.  The main objective in prostate brachytherapy is to irradiate the entire prostate, 
in addition to a margin to take into account seed displacement and potential 
extracapsular disease extension (ECE).  In most cases, the ECE is within 3 mm from the 
prostate edge.  Usually, the seeds are not implanted perfectly, causing implant-related 
prostate swelling.  Because of the relationship between the linear prostate dimensions 
and volume, there is a need for customized treatment planning for different patients.  As 
the prostate volume increases, the prostate linear dimensions changes gradually (Ove, et 
al. 2001). 
The process of prostate brachytherapy requires the services of a radiation 
dosimetrist.  Once the dosimetrist determines the placement, and activity of the 
radioactive seeds, and the duration of the implant, a radiation oncologist follows the 
dosimetrist’s plans and places the seeds into the prostate.  Prior to the implantation of the 
seeds, the patient is given guidelines regarding side effects and minimizing radiation 
exposure of his family.   
After implantation, computed tomography (CT) scans are usually performed for 
dosimetric analysis.  The challenge with CT scans is that post-implant edema usually 
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increases the prostate volume by over 50%.  With a typical half-life of 9 days, the edema 
decreases exponentially with time (Waterman & Dicker 1999). 
The side effects of this treatment are fatigue, skin reactions such as bruising, 
frequent and painful urination, diarrhea, and rectal bleeding.  According to one study, 
rectal bleeding or ulceration was associated with treatments with doses over 100 Gy to 
the prostate as the sources irradiated the rectal wall (Waterman & Dicker 1999).  
Although not as frequent as from surgeries, prostate brachytherapy can lead to temporary 
impotence and incontinence.  Many patients, however, have urinary problems such as 
polyuria, urgency, incomplete voiding, straining, and nocturia.  Acute urinary retention 
occurs in approximately 3%-22% of the patients that undergo prostate brachytherapy 
(Merrick, et al. 2000).  Once the treatment is complete, these side effects typically 
diminish2.  
 As stated above, the brachytherapy process begins with the dosimetrist who plans 
the outline of the seed placement.  First, the dosimetrist obtains an ultrasound recording 
of the patient’s prostate.  Using computer software, the dosimetrist examines the prostate 
and places a two dimensional grid on the prostate image, with the center of the grid 
placed directly over the center of the gland.  The dosimetrist takes the three-dimensional 
organ and creates multiple ultrasound views of the prostate from all sides.  Then, each of 
the ultrasound views of the prostate is outlined to create two-dimensional surfaces3. 
                                                 
2 Personal Communication: Dr. George Warner, May 2002. 
3 Personal Communication: Mrs. Elizabeth Dodge, July 2002. 
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 After the dosimetrist maps the prostate from various views, computer software is 
used to determine the seed placement.  The default seed placement is dependent on the 
size of the prostate and will usually place more seeds and/or needle insertions on larger 
prostates.  Once the default seeds are displayed, isodose curves appear.  The main 
objective of the dosimetrist is to ensure that the entire prostate is adequately irradiated 
without delivering a significant dose to certain critical areas beyond the prostate.  Thus, 
the seeds, with the needles, are distributed appropriately so that the isodose curve 
surrounds the prostate gland and goes beyond the prostate only by about 3-4 mm. The 
dosimetrist tries to minimize radiation doses to the urethra and the rectal area. The 
dosimetrist places the seeds external to the prostatic urethra4.   
In interstitial brachytherapy planning, dose homogeneity is desired to uniformly 
irradiate the target tissues.  Many methods have been used, such as the “inverse dose-
rate effect” and less dose distribution to the urethra and rectum (D’Souza & Meyer 
2001).  Treatment planning for prostate brachytherapy is performed by assuming that the 
seeds are point source emitters in a homogeneous phantom.  In the study of planning 
procedures, a Task Group report (TG-43) with dosimetric protocols was used to 
standardize dosimetric parameters for specific seed designs, which were measured in 
water (DeMarco, et al.1999). 
Sample seed placements for 125I and 103Pd seeds are given in Figs. 1 and 2, 
respectively (provided courtesy of Elizabeth Dodge of Cancer Therapy and Research 
Center [CTRC], San Antonio). These two examples were for patients with different 
                                                 
4 Personal Communication: Mrs. Elizabeth Dodge, July 2002. 
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prostate sizes, leading to slight differences in their therapies.  These figures show two-
dimensional seed placements on the prostate cross-section.  For purposes of this 
research, these sample distributions were used in the MCNP codes for calculating the 
doses to the critical organs from these two sources.  The geometrical shapes represent 
the different retractions of the needle placements.  These retractions are the distances 
from the prostate surface where the needles are to be inserted to implant the seeds.  The 
numbers inside each of the needle placements represent the number of seeds in those 
needles.  As stated above, these arrangements were based on the isodose curve, which is 
calculated by the dosimetrist5. 
 
 
Fig. 1: Seed placement in prostate cross section (125I) 
 
                                                 
5 Personal Communication: Mrs. Elizabeth Dodge, July 2002. 
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Fig. 2: Seed placement in prostate cross section (103Pd) 
 
 
This seed arrangement ensures that the entire prostate is irradiated while 
restricting the dose outside the surface of the gland.  These figures show the seeds in the 
needles as they are placed into the prostate as well as the retraction of some of the 
placements.  The retraction refers to the depth from the prostate surface at which the 
seeds are implanted.  The urethra passes through the cross-section of the prostate, which 
is the reason for placing the seeds peripherally.  The region at the bottom of the prostate, 
just below the prostate’s fold, is the area that rests on the rectum.  Once the dosimetrist 
determines the seed placement in the prostate with the number of seeds per needle, and 
the activity per seed, the seeds and needles are ordered. 
 The dose delivered to the prostate during brachytherapy is generally large. The 
placement of the seeds is highly dependent on the size of the prostate.  For the 125I 
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example, there were 25 needles used with a total of 98 seeds, each with an activity of 
0.31 mCi.  For the 103Pd example, there were 29 needles used with a total of 115 seeds, 
each with an activity of 1.4 mCi.  Since the seeds remain in the prostate, the dose 
represents that delivered by the “total decay” of the radionuclide. 
ULTRASOUND GRAPHS OF THE SEEDS IN PROSTATE 
 For the cases shown in Figs. 1 and 2, ultrasound graphs have been provided for 
the therapy.  These ultrasound graphs show the seeds placed in the prostate cross-section 
with isodose curves for the prostate, the urinary bladder, the rectum, and the urethra.  
The ultrasound graphs show two-dimensional views of the isodose curves from various 
cross-sectional views of the prostate. The ultrasound views are shown in Figs. 3, 4, 5, 
and 6 for the 125I case and Figs. 7, 8, 9, and 10 for the 103Pd case (provided courtesy of 
Elizabeth Dodge of CTRC, San Antonio). 
 The isodose curves for the bladder, prostate, urethra, and rectum were used for 
dosimetric purposes so that the seeds could be arranged uniformly without significantly 
irradiating the bladder neck and the rectal area.  The isodose curves represent the 
minimum doses to the areas of the prostate where they lie.  As stated above in Figs. 1 
and 2, the urethra passes through the prostate’s cross section, which is the reason for the 
seeds being placed away from the center and the isodose curves not reaching the center.  
The rectum lies just below the prostate and as a result, the seeds are also distributed 
away from the rectum. Because the 125I and 103Pd cases were for two different patients 
with different prostate sizes, the seed distributions were also different.  The nuclides 
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have different emission energies; thus it was necessary to distribute the seeds differently 
to protect the rectum and urethra.  
Fig. 3: Posterior view of prostate (125I) 
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Fig. 4: Interior view of prostate (125I) 
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Fig. 5: Cross-sectional view of prostate (125I) 
 
 
Fig. 6: Rectal view of prostate (125I) 
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Fig. 7: Posterior view of prostate (103Pd) 
 
 16
Fig. 8: Interior view of prostate (103Pd) 
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Fig. 9: Cross-sectional view of prostate (103Pd) 
 
Fig. 10: Rectal view of prostate (103Pd) 
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CHAPTER III 
 MATERIALS AND METHODS 
MONTE CARLO N-PARTICLE 
Monte Carlo N-Particle (MCNP) is a computational code that can be used for 
various applications.  The code uses a calculation method called Monte Carlo simulation 
to calculate the quantities of interest in various complex geometries.  Because of this 
property, it was a useful tool in determining the radiation-absorbed doses to the organs 
of interest in the prostate brachytherapy process.  The version of MCNP used in this 
research was 4C (Briesmeister 2000). 
 The MCNP code is setup with entries that are used to create the model of 
interest.  The first set of entries is referred to as a cell card.  These entries are used to 
setup the areas of interest and combine surfaces by using union, intersection, or 
complement operators.  These cells are important for the determining region in which 
the user wishes to calculate the quantity of interest (i.e., energy deposition, energy 
fluence).   
The next set of entries is referred to as a surface card.  These entries are used to 
define the surfaces that make up the cells of interest.  The surfaces that MCNP can 
model are basic three-dimensional shapes such as spheres, cylinders, torri, and cones.  
The code can model two-dimensional planes that can be used to set upper and lower 
boundaries for three-dimensional geometries with infinite dimensions, such as cylinders.   
The third set of entries is referred to a material card.  These entries are used to 
specify the material composition of the cells, in terms of the chemical composition.  
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These can be entered using the atomic numbers and mass numbers of the elements 
followed by either percent or atomic compositions.  Once all necessary cards have been 
entered, the model has been setup with the surfaces and the materials. 
 Once the three main cards have been setup, the next step is to define the sources, 
particle types, number of particle histories, and types of tally calculations to be 
performed.  Since the code can be used to calculate interactions by neutrons, electrons, 
and photons, the mode needs to be entered so that the code will calculate the interactions 
for the appropriate radiation (n=neutrons, p=photons, e=electrons).  The number of 
particle histories must be entered and should be selected to provide the required 
statistical accuracy.  The sources can be setup either as Cartesian sources such as point 
and line sources, or as three-dimensional sources such as spherical and cylindrical 
sources.  The source information must be entered with particle energies, source 
positions, and emitted particle types specified by number (neutrons=1, photons=2, 
electrons=3).  After the source information has been entered, tally cards are entered 
which define the calculations of interest, such as energy fluence, energy deposition in 
mass, and energy pulse.  Once the sources, particle histories, and tallies are entered, the 
code is completed with the “print” command at the end.  When all these steps are 
completed, the user is ready to execute the codes and perform calculations.  The 
execution of the codes is complete when all particle histories have been followed. 
COMPUTER MODELING 
 In many cases, computer modeling is necessary for simulating complex 
situations, such as the irradiation of a human organ because many issues such as 
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geometry and target materials must be considered.  One form of modeling uses an 
independent dose-to-point calculation program for a high-dose-rate prostate 
brachytherapy planning system.  This program can be used by hospitals to verify the 
doses in brachytherapy planning (Cohen, et al. 2000).  A Monte Carlo technique can be 
used to calculate many parameters, such as dose rates as a function of photon energies 
by using the photon-energy spectrum of the radionuclide (Rivard 2001).   
SABRINA BODYBUILDER 
 Sabrina Bodybuilder is a software package that can be used to model a male or a 
female from a newborn to a 21-year old as well as pregnant women and phantoms with 
male and female reproductive organs.  The software also can show graphically the 
phantoms that are being modeled in an MCNP code. 
 The software has all the equations for the major skeletal bones, organs of the 
gastrointestinal tract, lungs, kidneys, brain, adrenals, spleen, thyroid, thymus, and skin.  
For the male, the software has equations for the genitals, which includes the penis and 
the scrotum in addition to their skin.  For the female, the software has equations for the 
ovaries and the cervix. These equations create a mathematical phantom that can be used 
to model various situations, from internal dosimetry in brachytherapy to external 
dosimetry in external beam therapy.  Because these equations are based on typical 
phantoms used for dosimetry, some organs, such as the prostate, are not available in the 
codes.  Because of this, it would be necessary for the user to model these organs based 
on the geometries and the positions of the other organs modeled with Sabrina 
Bodybuilder.   
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PROCEDURES 
 Using Sabrina Bodybuilder, an 18-year old male was modeled with most of the 
organs in the lower trunk as well as the major organs in the upper trunk.  Once the 
phantom was created, the organs of interest were selected that were likely to receive 
significant doses from prostate brachytherapy.  The organs of interest were the leg 
bones, the pelvis, the spine (upper, middle, lower), the ribs, the stomach wall, the small 
intestine wall, the large intestine wall (ascending, transverse, descending, sigmoid), the 
kidneys, the liver, the lungs, the testicles, the urinary bladder wall, the penis and scrotum 
(with skin), and the legs (with skin).  Since the prostate was not included in Sabrina 
Bodybuilder, it was added into the code and was set between the urinary bladder and the 
genitalia as a sphere with radius of 2.5 cm.  Spherical shape was used in prostate 
modeling rather than an ellipsoidal shape to simplify the geometry by using a single 
radius as opposed to major and minor axes. 
 Once the organs were selected and the prostate was added, the source card was 
setup.  Point sources were used for source definitions, were distributed inside the volume 
of the prostate gland and were laid out with arrangements discussed previously.  Two 
codes were created to simulate the therapy: one for 125I and the other for 103Pd.  For 125I, 
a total of 98 point sources were arranged with each source emitting photons of 35.49 
keV.  For 103Pd, a total of 115 point sources were arranged with each source emitting 
photons of 21 keV.  Since both radionuclides decay via electron capture, they emit 
Auger electrons and photons.  Because of this decay mode, the modes considered in both 
codes were electron and photon transport, however, the energy deposited in the organs 
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was due entirely to photons (Nath, et al. 1995).  The coordinates for each of the seeds 
used in both 125I and 103Pd treatments are given in Appendix A.  
 After the source cards were entered for both codes, the tally cards were entered to 
allow calculation of the energy deposited in the organs of interest.  The doses from 
electrons cannot be calculated by using MCNP.  Because of the constraint with electron 
transport and calculating energy deposition in mass tallies, it was necessary to calculate 
the energy deposited (in MeV) and then calculate the doses using known densities and 
volumes of the tissues, given in Sabrina Bodybuilder. 
 Finally, once the necessary cards were entered, the number of particle histories 
was entered for both of the codes.  For both 125I and 103Pd, 10,000,000 particle histories 
were selected. This number of histories was considered to provide reasonable statistical 
accuracy with minimal execution time.  Once all of the necessary information was 
entered, the codes were set to execute, which calculated the energy deposited in the 
regions of interest. 
The phantom was created in a Cartesian coordinate system (x,y,z).  The origin of 
the coordinate system was in the center of the phantom just below the pelvic region.  The 
x-axis was the horizontal axis that traversed the phantom (width of phantom).  The y-
axis was the axis from the front of the phantom to the rear (depth of phantom).  The z-
axis was the vertical axis from the head to the feet (height of phantom).  The prostate 
was designed as a sphere with a radius of 2.5 cm and its center at (0, -6.0025, 2.805), 
just between the urinary bladder and the genitals.  The position and size of the prostate is 
described by: 
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6.25 = x2 + (y + 6.0025)2 + (z - 2.805)2.    (1) 
The geometry for the male phantom from the lateral view (cut at x=2) is shown in Fig. 
11.  An anterior view of the phantom (cut at y=2) is shown in Fig. 12.  A lateral view of 
the mid-section of the phantom (cut at y=2 and extent=20) with the prostate position 
with respect to the urinary bladder is shown in Fig. 13. The extent command magnifies 
the area of interest on the plot of the geometry. 
 
 
Fig. 11: Side view (cut at x=2) of male phantom 
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Fig. 12: Anterior view (cut at y=2) of male phantom 
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Fig. 13: Lateral view of the prostate region (cut at y=2) 
 
 
 The figures show the various views of the 18-year old male phantom with the 
internal organs. The shapes of the organs of the phantom modeled were approximate to 
actual human organs.  Many of the organs in the actual human body, particularly in the 
pelvic region are squeezed together and are not as far apart as the figures show.  Many of 
the actual human organs, such as the prostate and the bladder even have close contact 
with each other, which is not represented by the above figures.  Using this 18-year old 
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male phantom, the doses to the organs of interest were calculated using the Monte Carlo 
technique.  Because actual therapy cases were used in the MCNP model, these doses 
were considered to be representative of the doses the organs would receive through this 
therapy.   
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CHAPTER IV 
 RESULTS 
MCNP RESULTS 
 Once the codes were executed, the energy deposited  (in MeV) in each organ of 
interest was determined (see Appendix B for the input files).  The doses to the organs of 
interest were consistent with the distance from the prostate for both, 125I and 103Pd.  
Generally, the energies deposited in the organs were higher in the 125I case than in the 
103Pd case as expected due to the higher energy photons emitted by 125I.   
DOSES TO THE CRITICAL ORGANS 
 Once the imparted energies were calculated, the absorbed doses per 
transformation (in Gy trans-1) were calculated using known densities and volumes of the 
organs.  These doses represented the radiation absorbed doses per transformation in the 
organs of the phantom modeled in the codes.  These doses are shown in Table 1. 
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Table 1: Calculated doses to organs in phantom 
Organ 
Organ 
Density 
(g cm-3) 
Organ 
Volume 
(cm3) 
125I 
Absorbed 
Energy 
Per Trans 
(MeV 
trans-1) 
103Pd 
Absorbed 
Energy 
Per Trans 
(MeV 
trans-1) 
125I 
Absorbed 
Dose Per 
Trans (Gy 
trans-1) 
103Pd 
Absorbed 
Dose Per 
Trans (Gy 
trans-1) 
Leg Bones 1.4 2.5X103 1.1X10-3 1.6X10-3 5.2X10-17 2.37X10-18
Pelvis 1.4 5.3X102 4.7X10-4 6.6X10-4 1.0X10-16 2 X10-18 
Lower Spine 1.4 4.3X102 1.8X10-6 1.4X10-4 4.7X10-19 0.00 
Middle Spine 1.4 3.3X102 3.4X10-8 3.9X10-6 1.2X10-20 0.00 
Upper Spine 1.4 1.1X102 2.8X10-9 2.8X10-20 3.0X10-21 0.00 
Ribs 1.4 6.1X102 3.2X10-7 5.4X10-7 6.0X10-20 1.05 X10-21
Stomach 1.04 1.3X102 1.4X10-7 3.0X10-7 1.6X10-19 0.00 
Small 
Intestine 1.04 9.3X102 4.1X10-5 6.9X10-5 7.0X10-18 1.27 X10-20
Ascending 
Colon 1.04 80.00 3.6X10-6 5.9X10-6 7.0X10-18 1.19 X10-20
Transverse 
Colon 1.04 1.1X102 1.0X10-6 1.9X10-6 1.5X10-18 0.00 
Descending 
Colon 1.04 79.00 2.1X10-5 3.1X10-5 4.1X10-17 1.1 X10-18
Sigmoid 
Colon 1.04 62.00 1.4X10-3 1.1X10-3 3.3X10-15 1.15 X10-15
Kidneys 1.04 2.6X102 1.9X10-7 4.6X10-7 1.1X10-19 0.00 
Liver 1.04 1.6X103 5.6X10-7 1.4X10-6 5.4X10-20 0.00 
Lungs 0.3 2.8X103 2.0X10-8 5.5X10-8 3.8X10-21 3.77 X10-22
Testes 1.04 26.00 1.4X10-4 1.6X10-4 8.2X10-16 2.08 X10-16
Urinary 
Bladder 1.04 40.00 1.3X10-4 1.4X10-4 4.8X10-16 7.49 X10-17
Penis & 
Scrotum 1.04 1.3X102 8.8X10-4 9.1X10-4 1.1X10-15 4.09 X10-16
Penis & 
Scrotum Skin 1.04 18.00 4.1X10-5 4.9X10-5 3.4X10-16 7.91 X10-17
Leg Skin 
(Left) 1.04 5.2X102 1.9X10-5 2.5X10-5 5.5X10-18 1.4 X10-18
Leg Skin 
(Right) 1.04 5.2X102 9.6X10-6 1.2X10-5 2.8X10-18 2.96 X10-19
Legs 1.04 1.5X104 6.6X10-3 7.1X10-3 6.9X10-17 2.27 X10-17
Prostate 1.04 16.00 1.3X10-3 1.3X10-3 1.2X10-14 8.32 X10-15
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The doses shown on Table 1 represent the doses per particle history to the organs 
at the time of implantation.  To assess the actual doses the organs of interest, these doses 
must be evaluated over a period equal to total decay of the radionuclide.  Because of 
this, it was necessary to calculate the total number of transformations that would occur in 
the sources over this time period.  The activity, which represents the number of 
transformations per second, is given by Equation (2):  
    A = A0 e-λt     (2) 
where A= Activity at time t in bequerels (Bq);  
           A0= Initial activity in bequerels (Bq); 
           λ= Decay constant of the radionuclide (s-1); and 
           t= Time from the initial decay to the final decay (s). 
The decay constant, λ, can be determined using the half-life of the radionuclide and is 
calculated using Equation (3): 
1 / 2
ln 2
T
λ =        (3) 
where T1/2 represents the half-life.  Using Equations (2) and (3), the number of 
transformations occurring can be calculated for any time period. But, in this research, an 
infinite time was of interest because the lifetime patient doses were the main interest.  
Using Equation (4), the total number of transformations (Us) can be determined over an 
infinite time period: 
0
0
t
sU A e dtλ
∞
−= ∫     (4). 
The solution for this equation over an infinite time interval is given by Equation (5): 
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0
s
AU λ=     (5). 
 Once the total number of transformations has been determined, the total dose (in 
Gy) to the organs can be calculated using Equation (6): 
Absorbed Dose = 1.602X10-10 ∑i US SEE(T←S)i m-1  (6) 
where 1.602X10-10 = conversion factor from MeV to J and g to kg; 
SEE(T←S) = specific effective (absorbed) energy transferred from source to  
target (MeV), here the radiation quality factor is unity for photons;   
and 
m = mass of the target organ (g). 
The mass of the target organs was calculated using the known densities and volumes of 
the organs, created by Sabrina Bodybuilder.  Once the calculations were performed, the 
dose to each of the organs was calculated.  The results represented the doses the male 
phantom received from these brachytherapy seeds, which were representative of the 
doses the patient would receive during his lifetime.  The results of the calculations are 
given in Table 2. 
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Table 2: Calculated lifetime doses to the phantom 
Organ 
125I 
Transformation 
Over Infinite 
Period 
103Pd 
Transformation 
Over Infinite 
Period 
125I 
Lifetime 
Dose 
(Gy) 
103Pd 
Lifetime 
Dose 
(Gy) 
Leg Bones 8.3X1015 1.3X1016 0.43 3X10-2 
Pelvis 8.3X1015 1.3X1016 0.84 0.03 
Lower Spine 8.3X1015 1.3X1016 3.9X10-3 0.00 
Middle Spine 8.3X1015 1.3X1016 1.0X10-4 0.00 
Upper Spine 8.3X1015 1.3X1016 2.5X10-5 0.00 
Ribs 8.3X1015 1.3X1016 5.0X10-4 1.33X10-5
Stomach 8.3X1015 1.3X1016 1.4X10-3 0.00 
Small 
Intestine 8.3X1015 
1.3X1016 
0.06 1.6X10-4
Ascending 
Colon 8.3X1015 
1.3X1016 
0.06 1.5X10-4
Transverse 
Colon 8.3X1015 
1.3X1016 
0.01 0.00 
Descending 
Colon 8.3X1015 
1.3X1016 
0.34 1.38X10-2
Sigmoid 
Colon 8.3X1015 
1.3X1016 
27.85 14.45 
Kidneys 8.3X1015 1.3X1016 9.1X10-4 0.00 
Liver 8.3X1015 1.3X1016 4.5X10-4 0.00 
Lungs 8.3X1015 1.3X1016 3.1X10-5 4.75X10-6
Testes 8.3X1015 1.3X1016 6.80 2.62 
Urinary 
Bladder 8.3X1015 
1.3X1016 
4.00 1.00 
Penis & 
Scrotum 8.3X1015 
1.3X1016 
8.90 5.16 
Penis & 
Scrotum Skin 8.3X1015 
1.3X1016 
2.90 1.00 
Leg Skin 
(Left) 8.3X1015 
1.3X1016 
0.05 1.8X10-2
Leg Skin 
(Right) 8.3X1015 
1.3X1016 
0.02 3.74X10-3
Legs 8.3X1015 1.3X1016 0.58 0.29 
Prostate 8.3X1015 1.3X1016 102.40 105.00 
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 As shown in Table 2, the 18-year old male phantom received prostate doses of 
approximately 102 Gy and 105 Gy from 125I and 103Pd, respectively.  Since the activity 
of the 103Pd seeds was higher than that for 125I, a slightly higher dose to the prostate 
gland was expected. Generally, 125I delivered higher doses to the organs compared to 
103Pd and in both cases, the organs nearest to the prostate received the highest doses, 
while the organs more distant from the prostate received the lowest doses, which was 
expected for these radiation therapies.  The organs that received significantly high doses 
were the penis and scrotum, the urinary bladder, the testicles, and the sigmoid colon.  
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CHAPTER V 
 DISCUSSION AND CONCLUSIONS 
DISCUSSION 
 These absorbed doses were approximately what patients would receive from 
prostate brachytherapy from either 125I or 103Pd.  The use of Monte Carlo calculations 
allowed this task to be completed successfully, which would have been extremely 
complicated with conventional mathematics due to the complex geometries as well as 
issues such as attenuation and buildup.   
As expected, the doses to the prostate were in the range above 100 Gy.  Also as 
expected, the prostate doses from both nuclides were approximately the same, since the 
103Pd case had more seeds with lower photon energies compared to the 125I case, which 
had lower number of seeds with higher photon energies.  The urinary bladder, sigmoid 
colon, testes, and penis and scrotum received the highest doses from the radioactive 
sources in the prostate, which was expected due to their proximity to the prostate.  
Generally, the doses to the other organs were below 1 Gy and the organs more distant 
from the prostate such as those near the rib cage were much less than 1 Gy. 
Even though these doses were representative of the actual cases, there are some 
factors that must be considered.  The phantom used to perform the modeling was based 
on a body of an 18-year old male.  This phantom was used because there were no 
phantoms representing 70 year-old males in Sabrina Bodybuilder.  Because of this, there 
would be slightly different values for the absorbed doses to the organs due to the varying 
skeleton volume, fat content in the trunk, and body mass.  However, because the 
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differences in the sizes and positions of the organs between young adult males and 
elderly males are generally in the millimeter range, the differences are minimal.  Another 
factor that must be taken into account is that the prostate was modeled as a sphere with a 
diameter of 5 cm, which is not actually the case in most males.  The sizes and shapes of 
prostates can vary from patient to patient, which would lead to varying results. 
Presently, health effects are neither a concern to the patients, nor to the 
physicians because of the overall effect in treating tumors.  Although there may be a risk 
of getting secondary cancers over many decades, this therapy is generally preferred over 
the certainty of dying from prostate cancer.  Because prostate cancer occurs during the 
later years of the individual’s life, the probability of adverse health effects from this 
treatment would not be a major concern for the patients, especially because the treatment 
will save their lives from a terminal illness to which they will definitely succumb 
without treatment. Because of this, prostate brachytherapy can continue to be an 
effective procedure in treating prostate cancer and increasing the years of life for the 
patients. 
However, risk assessments can be performed by considering the risks of getting 
fatal cancers and risk coefficients provided by the International Commission on 
Radiation Protection (ICRP 1990).  Using these coefficients and the calculated doses to 
each of the organs, the risk of getting fatal cancer can be calculated for each organ as 
well as for the individual.  Because the energies emitted were due to photons, the dose is 
equal to the dose equivalent, since the radiation weighing factor is one, so 1 Gy equals 1 
sievert (Sv).  Since the doses to the red bone marrow, thyroid, breast, esophagus, and 
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ovary were not calculated, the dose equivalents to these organs were not considered.  
Since hereditary effects are not significant, the testes were not included in the risk 
assessment.  The calculated risks are given in Table 3. 
Table 3: Fatal cancer risk assessment 
Organs Risk 
Coefficients 
(Sv-1) 
125I Organ 
Dose 
Equivalent 
(Sv) 
103Pd Organ 
Dose 
Equivalent 
(Sv) 
125I Fatal 
Cancer 
Risk 
103Pd Fatal 
Cancer 
Risk 
Bladder 3X10-3 4.00 1.00 1.2X10-2 3X10-3 
Bone 
Marrow 
5X10-3 0.00 0.00 0.00 0.00 
Bone 
Surface 
5X10-4 0.43 0.03 2.2X10-4 1.5X10-5 
Breast 2X10-3 0.00 0.00 0.00 0.00 
Colon 8X10-3 28.26 14.46 0.24 0.12 
Liver 1.5X10-3 4.5X10-4 0.00 6.8X10-7 0.00 
Lung 8.5X10-3 3.1X10-5 4.75X10-6 2.6X10-7 4.04X10-8 
Esophagus 3X10-3 0.00 0.00 0.00 0.00 
Ovary 1X10-3 0.00 0.00 0.00 0.00 
Skin 2X10-4 2.97 1.02 5.9X10-4 2.04X10-4 
Stomach 1.1X10-2 1.4X10-3 0.00 1.5X10-5 0.00 
Thyroid 8X10-4 0.00 0.00 0.00 0.00 
Kidney 5X10-3 9.1X10-4 0.00 4.6X10-6 0.00 
Total 5X10-2   2.53X10-1 1.26X10-1 
 
The calculated risks for fatal cancer to the individual from 125I and 103Pd were 
about 25% and 13%, respectively.  As expected, the risk of developing fatal secondary 
cancers was higher in 125I because of the higher photon energies.  The organs that had 
the highest risk of developing fatal cancers were the urinary bladder and the colon, 
which was expected since these organs were adjacent to the prostate.  However, the 
organ that contributed the significant risk of developing fatal cancer was the colon, due 
to the high dose delivery to the sigmoid colon by both sources. 
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FUTURE WORK 
 Although this research involved the use of actual brachytherapy cases, they do 
not necessarily represent the exact doses the patients are receiving due to geometric 
factors and distances between the organs.  Because of these factors, there are 
recommendations for future work. 
A recommendation for future research is to use tissue equivalent phantoms using 
brachytherapy seeds and placing dosimeters in the regions of interest.  This project 
would probably provide more accurate results because this would eliminate the 
discrepancy with the sizes of the organs, particularly the prostate.  This would also help 
in eliminating the complications of distances between the organs. 
Another recommendation for future research is to create a phantom of an elderly 
male and to write an MCNP code based on this phantom.  Some potential differences 
between the 18-year old and the elderly male phantoms would be in their masses, 
heights, fat content, and varying bone masses.  Among many other factors, these factors 
may impact the results obtained in this research because generally people lose weight 
and become shorter.  Because of this, many of the doses would probably be higher due 
to the closer distances to the prostate, considering the reduced muscle content in the 
elderly males as opposed to younger males.   
A third recommendation is to create a void between the organs in the pelvic 
region to account for the organ surfaces contacting each other by setting a vacuum 
between these organs.  Setting a void between these organs in the pelvic region will 
provide a more accurate account of the doses to these organs from prostate 
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brachytherapy, which are likely to be higher since there will be no material for the 
photons to interact before reaching the organs of interest. 
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APPENDIX A 
 
125I SEED PLACEMENTS 
Seed # Activity x y z 
1 0.31 mCi 0 -6.003 4.305 
2 0.31 mCi 0 -5.503 4.305 
3 0.31 mCi 0 -5.003 4.305 
4 0.31 mCi 0 -4.503 4.305 
5 0.31 mCi -1 -6.003 3.805 
6 0.31 mCi -1 -5.503 3.805 
7 0.31 mCi -1 -4.503 3.805 
8 0.31 mCi -0.5 -6.003 3.805 
9 0.31 mCi -0.5 -5.503 3.805 
10 0.31 mCi -0.5 -4.503 3.805 
11 0.31 mCi -0.5 -3.003 3.805 
12 0.31 mCi -0.5 -2.003 3.805 
13 0.31 mCi 0.5 -6.003 3.805 
14 0.31 mCi 0.5 -4.003 3.805 
15 0.31 mCi 0.5 -3.503 3.805 
16 0.31 mCi 0.5 -2.503 3.805 
17 0.31 mCi 0.5 -2.003 3.805 
18 0.31 mCi 1 -6.003 3.805 
19 0.31 mCi 1 -5.503 3.805 
20 0.31 mCi 1 -5.003 3.805 
21 0.31 mCi 1 -4.503 3.805 
22 0.31 mCi -1.5 -6.003 3.805 
23 0.31 mCi -1.5 -5.503 3.805 
24 0.31 mCi -1.5 -5.003 3.805 
25 0.31 mCi -1.5 -4.503 3.805 
26 0.31 mCi -1.5 -4.003 3.805 
27 0.31 mCi -1 -3.503 3.805 
28 0.31 mCi -1 -2.503 3.805 
29 0.31 mCi -1 -2.003 3.805 
30 0.31 mCi 1 -3.503 3.805 
31 0.31 mCi 1 -3.003 3.805 
32 0.31 mCi 1 -2.503 3.805 
33 0.31 mCi 1 -2.003 3.805 
34 0.31 mCi 1.5 -6.003 3.805 
35 0.31 mCi 1.5 -5.503 3.805 
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125I SEED PLACEMENTS (Con’t) 
Seed # Activity x y z 
36 0.31 mCi 1.5 -5.003 3.805 
37 0.31 mCi 1.5 -4.503 3.805 
38 0.31 mCi 1.5 -4.003 3.805 
39 0.31 mCi -2 -5.003 3.805 
40 0.31 mCi -2 -4.503 3.805 
41 0.31 mCi -1.5 -6.003 3.805 
42 0.31 mCi -1.5 -5.503 3.805 
43 0.31 mCi -1.5 -3.503 3.805 
44 0.31 mCi -1.5 -3.003 3.805 
45 0.31 mCi 2 -6.003 3.805 
46 0.31 mCi 2 -5.003 3.805 
47 0.31 mCi -2 -5.003 2.305 
48 0.31 mCi -2 -4.503 2.305 
49 0.31 mCi -2 -3.503 2.305 
50 0.31 mCi -2 -3.003 2.305 
51 0.31 mCi -1 -6.003 2.305 
52 0.31 mCi -1 -2.503 2.305 
53 0.31 mCi -1 -2.003 2.305 
54 0.31 mCi 1 -3.503 2.305 
55 0.31 mCi 1 -2.503 2.305 
56 0.31 mCi 1 -2.003 2.305 
57 0.31 mCi 2 -5.003 2.305 
58 0.31 mCi 2 -4.503 2.305 
59 0.31 mCi 2 -4.003 2.305 
60 0.31 mCi 2 -3.503 2.305 
61 0.31 mCi 2 -3.003 2.305 
62 0.31 mCi -2.5 -4.003 1.805 
63 0.31 mCi -2.5 -3.503 1.805 
64 0.31 mCi -1.5 -5.503 1.805 
65 0.31 mCi -1.5 -5.003 1.805 
66 0.31 mCi -1.5 -4.503 1.805 
67 0.31 mCi -1.5 -3.003 1.805 
68 0.31 mCi -1.5 -2.503 1.805 
69 0.31 mCi -0.5 -6.003 1.805 
70 0.31 mCi -0.5 -5.003 1.805 
71 0.31 mCi -0.5 -4.003 1.805 
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125I SEED PLACEMENTS (Con’t) 
Seed # Activity x y z 
72 0.31 mCi -0.5 -2.503 1.805 
73 0.31 mCi -0.5 -2.003 1.805 
74 0.31 mCi 0.5 -6.003 1.805 
75 0.31 mCi 0.5 -5.503 1.805 
76 0.31 mCi 0.5 -5.003 1.805 
77 0.31 mCi 0.5 -4.503 1.805 
78 0.31 mCi 0.5 -3.003 1.805 
79 0.31 mCi 0.5 -2.503 1.805 
80 0.31 mCi 0.5 -2.003 1.805 
81 0.31 mCi 1.5 -6.003 1.805 
82 0.31 mCi 1.5 -5.503 1.805 
83 0.31 mCi 1.5 -4.503 1.805 
84 0.31 mCi 1.5 -3.003 1.805 
85 0.31 mCi 1.5 -2.503 1.805 
86 0.31 mCi -2.5 -4.503 1.305 
87 0.31 mCi -2.5 -4.003 1.305 
88 0.31 mCi -2 -5.003 1.305 
89 0.31 mCi -2 -3.503 1.305 
90 0.31 mCi -2 -3.003 1.305 
91 0.31 mCi -2 -2.503 1.305 
92 0.31 mCi 1.5 -5.003 1.305 
93 0.31 mCi 1.5 -4.003 1.305 
94 0.31 mCi 2 -5.003 1.305 
95 0.31 mCi 2 -4.503 1.305 
96 0.31 mCi 2 -4.003 1.305 
97 0.31 mCi 2 -3.503 1.305 
98 0.31 mCi 2 -3.003 1.305 
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103Pd SEED PLACEMENTS 
Seed # Activity x y z 
1 1.4 mCi 0 -6.003 4.305 
2 1.4 mCi 0 -5.503 4.305 
3 1.4 mCi -1 -6.003 3.805 
4 1.4 mCi -1 -5.503 3.805 
5 1.4 mCi -0.5 -6.003 3.805 
6 1.4 mCi -0.5 -5.003 3.805 
7 1.4 mCi -0.5 -4.503 3.805 
8 1.4 mCi -0.5 -2.503 3.805 
9 1.4 mCi -0.5 -2.003 3.805 
10 1.4 mCi -0.5 -1.503 3.805 
11 1.4 mCi 0.5 -6.003 3.805 
12 1.4 mCi 0.5 -5.503 3.805 
13 1.4 mCi 0.5 -5.003 3.805 
14 1.4 mCi 0.5 -4.503 3.805 
15 1.4 mCi 0.5 -2.503 3.805 
16 1.4 mCi 0.5 -2.003 3.805 
17 1.4 mCi 0.5 -1.503 3.805 
18 1.4 mCi 1.5 -6.003 3.805 
19 1.4 mCi 1.5 -5.003 3.805 
20 1.4 mCi 1.5 -4.503 3.805 
21 1.4 mCi -1.5 -6.003 3.305 
22 1.4 mCi -1.5 -5.003 3.305 
23 1.4 mCi -1.5 -4.503 3.305 
24 1.4 mCi -1 -6.003 3.305 
25 1.4 mCi -1 -4.003 3.305 
26 1.4 mCi -1 -3.503 3.305 
27 1.4 mCi -1 -3.003 3.305 
28 1.4 mCi -1 -1.503 3.305 
29 1.4 mCi 1 -6.003 3.305 
30 1.4 mCi 1 -4.503 3.305 
31 1.4 mCi 1 -3.503 3.305 
32 1.4 mCi 1 -3.003 3.305 
33 1.4 mCi 1 -1.503 3.305 
34 1.4 mCi 2 -6.003 3.305 
35 1.4 mCi 2 -5.003 3.305 
36 1.4 mCi 2 -4.503 3.305 
37 1.4 mCi 2 -2.503 3.305 
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103Pd SEED PLACEMENTS (Con’t) 
Seed # Activity x y z 
38 1.4 mCi -2 -5.503 2.805 
39 1.4 mCi -2 -4.503 2.805 
40 1.4 mCi -2 -4.003 2.805 
41 1.4 mCi -1.5 -6.003 2.805 
42 1.4 mCi -1.5 -2.503 2.805 
43 1.4 mCi -1.5 -3.003 2.805 
44 1.4 mCi -1 -2.003 2.805 
45 1.4 mCi -1 -1.503 2.805 
46 1.4 mCi 1 -6.003 2.805 
47 1.4 mCi 1 -2.003 2.805 
48 1.4 mCi 1 -1.503 2.805 
49 1.4 mCi 1.5 -6.003 2.805 
50 1.4 mCi 1.5 -4.003 2.805 
51 1.4 mCi 1.5 -2.503 2.805 
52 1.4 mCi 2.5 -5.003 2.805 
53 1.4 mCi 2.5 -4.503 2.805 
54 1.4 mCi -2 -5.503 2.305 
55 1.4 mCi -2 -4.503 2.305 
56 1.4 mCi -2 -3.003 2.305 
57 1.4 mCi -2 -2.503 2.305 
58 1.4 mCi -1 -6.003 2.305 
59 1.4 mCi -1 -5.503 2.305 
60 1.4 mCi -1 -2.003 2.305 
61 1.4 mCi -1 -1.503 2.305 
62 1.4 mCi 1 -6.003 2.305 
63 1.4 mCi 1 -2.003 2.305 
64 1.4 mCi 1 -1.503 2.305 
65 1.4 mCi 2 -6.003 2.305 
66 1.4 mCi 2 -5.503 2.305 
67 1.4 mCi 2 -4.003 2.305 
68 1.4 mCi 2 -3.503 2.305 
69 1.4 mCi 2 -2.503 2.305 
70 1.4 mCi -2.5 -4.503 1.805 
71 1.4 mCi -2.5 -4.003 1.805 
72 1.4 mCi -2.5 -3.503 1.805 
73 1.4 mCi -1.5 -5.503 1.805 
74 1.4 mCi -1.5 -4.503 1.805 
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103Pd SEED PLACEMENTS (Con’t) 
Seed # Activity x y z 
75 1.4 mCi -1.5 -4.003 1.805 
76 1.4 mCi -1.5 -2.503 1.805 
77 1.4 mCi -1.5 -2.003 1.805 
78 1.4 mCi -0.5 -6.003 1.805 
79 1.4 mCi -0.5 -5.503 1.805 
80 1.4 mCi -0.5 -5.003 1.805 
81 1.4 mCi -0.5 -4.003 1.805 
82 1.4 mCi -0.5 -3.003 1.805 
83 1.4 mCi -0.5 -2.503 1.805 
84 1.4 mCi -0.5 -2.003 1.805 
85 1.4 mCi -0.5 -1.503 1.805 
86 1.4 mCi 0.5 -6.003 1.805 
87 1.4 mCi 0.5 -5.003 1.805 
88 1.4 mCi 0.5 -4.503 1.805 
89 1.4 mCi 0.5 -3.503 1.805 
90 1.4 mCi 0.5 -3.003 1.805 
91 1.4 mCi 0.5 -2.003 1.805 
92 1.4 mCi 0.5 -1.503 1.805 
93 1.4 mCi 1.5 -5.503 1.805 
94 1.4 mCi 1.5 -5.003 1.805 
95 1.4 mCi 1.5 -4.503 1.805 
96 1.4 mCi 1.5 -4.003 1.805 
97 1.4 mCi 1.5 -3.503 1.805 
98 1.4 mCi 1.5 -3.003 1.805 
99 1.4 mCi 1.5 -2.503 1.805 
100 1.4 mCi 1.5 -2.003 1.805 
101 1.4 mCi 2.5 -5.003 1.805 
102 1.4 mCi 2.5 -4.503 1.805 
103 1.4 mCi 2.5 -3.503 1.805 
104 1.4 mCi 2.5 -2.503 1.805 
105 1.4 mCi -2.5 -4.003 1.305 
106 1.4 mCi -2.5 -3.503 1.305 
107 1.4 mCi -2 -5.003 1.305 
108 1.4 mCi -2 -4.003 1.305 
109 1.4 mCi -2 -3.003 1.305 
110 1.4 mCi -2 -2.503 1.305 
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103Pd SEED PLACEMENTS (Con’t) 
Seed # Activity x y z 
111 1.4 mCi 2 -5.503 1.305 
112 1.4 mCi 2 -4.003 1.305 
113 1.4 mCi 2 -3.003 1.305 
114 1.4 mCi 2.5 -5.003 1.305 
115 1.4 mCi 2.5 -3.503 1.305 
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APPENDIX B 
125I INPUT FILE 
 
Male Phantom at  18.0 Years 
c +++++++++++++++++++++++++++++++++++++++++ 
c 
c    File Prepared by Body Builder 
c    CopyRight 1996-1998, White Rock Science 
c 
c    This input file is for the use of 
c    BodyBuilder License holder only. 
c    Distribution is Prohibited. 
c 
c +++++++++++++++++++++++++++++++++++++++++ 
c 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c           CELLS 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c SkeletonVolume = 6366.150000, skel_vol = 6303.571429 
c 
c         LEG BONES 
1      2 -1.40    -4 53 (-51:-52) 
                 vol=  2450.00 imp:p,e = 1 
c 
c         ARM BONES 
2     2 -1.40     4 -73 (-71:-72) 
                 vol=   843.50 imp:p,e = 1 
c 
c         PELVIS 
3     2 -1.40     91 -92 93 4 -101 (95:-94) 
                 vol=   533.00 imp:p,e = 1 
c 
c         SPINE 
4    2 -1.40   -100 -103 101 vol= 434.2500 imp:p,e = 1 
5    2 -1.40   -100 -8   103 vol= 325.6875 imp:p,e = 1 
6    2 -1.40   -105 -102 8   vol= 108.5625 imp:p,e = 1 
c               Total Spine vol=   868.50 
c 
c         SKULL & FACE 
7    2 -1.40   (111 -110):(121 -120 122 -1 -123 110)  
                 vol=   832.50 imp:p,e = 1 
c 
c         RIBS 
8    2 -1.40    132 -131 ((134 -133):(136 -135):(138 -137):(74 -139): 
                 (76 -75):(78 -77):(80 -79):(82 -81):(84 -83): 
                 (86 -85):(88 -87):(98 -89)) 
                 vol=   612.50 imp:p,e = 1 
c 
c         CLAVICLES 
9    2 -1.40    -140 ((141 -143):(-142 144)) 
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                 vol=    48.15 imp:p,e = 1 
c 
c         SCAPULAE 
10    2 -1.40     131 -156 154 -155 ((150 -152):(-151 153)) 
                 vol=   178.00 imp:p,e = 1 
c 
c         BRAIN 
11     1 -1.04    -111 
                 vol=  1360.00 imp:p,e = 1 
c 
c 
c         STOMACH  Wall 
14   1 -1.04       -210 211 
                 vol=   132.50 imp:p,e = 1 
c                  Contents 
15   1 -1.04       -211 
                 vol=   218.50 imp:p,e = 1 
c 
c         SMALL INTESTINE 
16   1 -1.04       -91 221 -222 223 -7 
C                exclude         Ascending Colon     
                        (232:230:-223) 
c                exclude         Transverse Colon     
                        (240 :241 :-242 ) 
c                exclude         Descending Colon     
                        (232:250:-223) 
                  vol=   933.00 imp:p,e = 1 
c 
c         ASCENDING COLON  Wall 
17   1 -1.04       -230 233 231 -232 
                  vol=    80.35 imp:p,e = 1 
c                          Contents 
18   1 -1.04       -233 231 -232 
                  vol=    84.85 imp:p,e = 1 
c 
c         TRANSVERSE COLON  Wall 
19   1 -1.04       -240 243 -241 242 
            vol=   106.65 imp:p,e = 1 
c                           Contents 
20   1 -1.04       -243 -241 242 
            vol=   111.50 imp:p,e = 1 
c 
c         DESCENDING COLON  Wall 
21   1 -1.04       -250 252 251 -232 
             vol=   79.10 imp:p,e = 1 
c                            Contents 
22   1 -1.04       -252 251 -232 
             vol=   90.10 imp:p,e = 1 
c 
c         SIGMOID COLON  Wall 
23   1 -1.04       (-280 282 -251):(-281 -282 4) 
             vol=   62.10 imp:p,e = 1 
c 
c         KIDNEYS 
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25     1 -1.04     (-310 312):(-311 -313) 
                  vol=   263.00 imp:p,e = 1 
c 
c         LIVER 
26     1 -1.04     -320 -321 7 -322 -132 
                   vol=  1590.00 imp:p,e = 1 
c 
c         LUNGS 
27     3 -0.296   332 ((-331 (-335:336:334:-333)): 
                        (-330 ( 339:338:337))) 
                 vol=  2790.00 imp:p,e = 1 
c 
c         TESTICLES 
28   1 -1.04       -370:-371 
             vol=   26.30 imp:p,e = 1 
c 
c         URINARY BLADDER  Wall 
29   1 -1.04       -410 411 
             vol=   40.10 imp:p,e = 1 
c                          Contents 
30   1 -1.04       -411 
             vol=  178.50 imp:p,e = 1 
c 
c         PENIS & SCROTUM 
31     1 -1.04       -1 -4 47 -45 49 -48 37 38 
c                exclude         Testicles 
                  370 371 
             vol=  126.20 imp:p,e = 1 
c 
c         SKIN 
c 
c              Head & Neck Skin 
32    1 -1.04       ((-21 22 9):(-20 23 -9 12)) 
                   imp:p,e = 1 
33    1 -1.04       28 -27 8 -12 
             vol=  284.50 imp:p,e = 1 
c            (Above Volume for Head + Neck Skin Combined 
c 
c           Trunk Skin 
34    1 -1.04       (-8 18 20 -10) 
                   : (4 -18 -10 11 
                  ) 
             vol= 1220.00 imp:p,e = 1 
c 
c         Penis & Scrotum Skin 
35     1 -1.04       -1 -4  41 -42 43 -44 31 32 #31 
c                exclude         Testicles 
                  370 371 
             vol=   18.45 imp:p,e = 1 
c        Legs Skin 
36    1 -1.04      (-4 34 -31 36 32):(-31 33 -36 32) 
             vol=  522.25 imp:p,e = 1 
37    1 -1.04      (-4 35 -32 36 31):(-32 33 -36 31) 
             vol=  522.25 imp:p,e = 1 
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c 
c            HEAD 
c 
38    1 -1.04       ((-22 9):(-23 -9 12)) 
c                exclude         Skull 
                        110 
c                exclude         Face Bones 
                        (-121:120:-122:1:123:-110) 
c                exclude         Spine 
                        (105:-8:102) 
                 imp:p,e = 1 
c 
c            NECK 
c 
39    1 -1.04       -28 8 -12 
c                exclude         Spine 
                         105 
                 imp:p,e = 1 
c 
c         OUTER TRUNK---ARMS & SCAPULAE 
c 
40    1 -1.04       4 131 -18 -11 
c                exclude         Scapulae 
                        (-131:156:-150:152:-154:155) 
                        (-131:156:151:-153:-154:155) 
c                exclude         Arm Bones 
                        (-4:71:73) (-4:72:73) 
                 imp:p,e = 1 
c 
c         UPPER TRUNK---ABOVE RIBS 
c 
41    1 -1.04   ((-18 -131 133) : (-8 18 -20 -10)) 
c                exclude         Spine 
                       (105:102:-8)(100:8:-133) 
c                exclude         Clavicles 
                       (140:-141:143) (140:142:-144) 
c                exclude         Upper Lungs 
                        (-133:330) (-133:331) 
                 imp:p,e = 1 
c 
c 
c         UPPER RIB CAGE 
c 
42    1 -1.04       -131 132 79 -133 
c                exclude         Ribs 1-9 
                  (131:-132:133:-134) (131:-132:135:-136) (131:-
132:137:-138) 
                  (131:-132:139:-74) (131:-132:75:-76) (131:-132:77:-
78) 
                 imp:p,e = 1 
c 
c 
c         LOWER RIB CAGE 
c 
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43    1 -1.04       -131 132 -79 98 
c                exclude         Ribs 10-12 
                  (131:-132:85:-86) (131:-132:87:-88) (131:-132:89:-98) 
                  (131:-132:79:-80) (131:-132:81:-82) (131:-132:83:-84) 
                 imp:p,e = 1 
c 
c 
c         HIGH CHEST ORGANS 
c 
44    1 -1.04       -132 -133 332 
c                exclude          Spine 
                        (100:133:-332) 
c                exclude          Lungs 
                        (330:133:-332:(-339 -338 -337)) 
                        (331:133:-332:(335 -336 -334 333)) 
                 imp:p,e = 1 
c 
c         CHEST---LIVER LEVEL 
c 
45    1 -1.04       ((-132 -332 98):(-131 -98 7)) 
c                exclude          Spine 
                        (100:332:-7) 
c                exclude          Kidneys 
                        (310:-312) (311:313) 
c                exclude          Liver 
                        #26 
c                       (320:321:322:-7) 
c                exclude         Stomach 
                       210 
                 imp:p,e = 1 
c 
c 
c         LOWER TRUNK 
c  
46    1 -1.04       -131 4 -7 
c                exclude           Spine  
                        (100:-101:7) 
c                exclude           Pelvis 
                        #3 
c                exclude           Small Intestine 
                        (91:-221:222:-223:7) 
c                exclude           Ascending Colon 
                        (232:230:-231) 
c                exclude           Descending Colon 
                        (232:250:-251) 
c                exclude           Sigmoid Colon 
                        (280:-282:251) (281:282:-4) 
c                exclude           Urinary Bladder 
                        410 
c                exclude           Prostate 
                        500 
                 imp:p,e = 1 
                 imp:p,e = 1 
c 
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c        LEGS 
c 
47    1 -1.04       -4 (-34:-35) 36 
c                exclude           Leg Bones 
                        (4:51:-53) (4:52:-53) 
             vol= 14605.50 imp:p,e = 1 
c 
c         SURROUNDING AIR 
48    4 -0.001293   -600 
c            exclude         HEAD & NECK 
                       (21:-9)  (20:9:-8) 
c            exclude         TRUNK 
                        (-4:10:8) 
c            exclude         LEGS 
                        (4:-33:(31 32)) 
c                exclude         GENITALIA 
                    (1:4:-41:42:-43:44:-31:-32) 
             imp:p,e = 1 
c            air            OUTSIDE of NECK 
49    4 -0.001293   -20 27 8 -12 
             imp:p,e = 1 
c 
c         PROSTATE 
70    1 -1.04  -500 vol= 16.3625 imp:p,e = 1 
c 
c         VOID 
50   0               600 
             imp:p,e = 0 
  
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c           SURFACES 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c Planes used in several places 
c 
1     py 0 
4     pz 0 
332   pz    41.3550 
7     pz    25.6700 
8     pz    66.5500 
9     pz    87.3000 
12    pz    74.6000 
c 
c         BODY SURFACE 
c 
c             HEAD 
21    sq  5280.8272  3394.8568  6597.4275 0 0 0 -343913.3409 0 0     
87.300 
22    sq  4831.0562  3077.0291  6069.0021 0 0 0 -300362.3462 0 0     
87.300 
20    sq   101.3042    65.1249 0 0 0 0 -6597.427523 0 0 0 
23    sq    97.6144    62.1732 0 0 0 0 -6069.002054 0 0 0 
c 
c 
c             NECK 
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27    cz     5.4850 
28    cz     5.3000 
c 
c 
c             TORSO 
10    sq   101.7072   353.8161 0 0 0 0 -35985.653691 0 0 0 
11    sq    98.0100   346.8906 0 0 0 0 -33998.750156 0 0 0 
18    pz    66.3650 
c 
c             LEGS 
c      left 
31    gq 1 1 0 0 0  -0.1862   -18.8100 0 0 0 
32    gq 1 1 0 0 0   0.1862    18.8100 0 0 0 
33    pz  -79.185 
34    gq 1 1 0 0 0  -0.1862   -18.6250 0 0 0 
35    gq 1 1 0 0 0   0.1862    18.6250 0 0 0 
36    pz  -79.000 
37    gq 1 1 0 0 0  -0.1862   -18.9950 0 0 0 
38    gq 1 1 0 0 0   0.1862    18.9950 0 0 0 
c 
c         PENIS & SCROTUM 
41    pz    -4.1750 
42    p  0 -10.74 -1 100.00 
43    p   -10.74 0 1 -100.00 
44    p    -10.74 0 -1 100.00 
47    pz    -3.9900 
45    p  0 -10.85 -1 100.00 
49    p   -10.85 0 1 -100.00 
48    p    -10.85 0 -1 100.00 
c 
c     SKELETON  
c 
c 
c         LEG BONES 
51    gq   1 1  0.007875 0 0  -0.186687   -18.625000 
            0   1.549817      76.0991 
52    gq   1 1  0.007875 0 0   0.186687    18.625000 
            0   1.549817      76.0991 
53    pz   -78.8150 
c 
c         ARM BONES ( left/right) ) 
71     gq   0.587190     0.139750 0 0 0     0.011681 
             -20.889300 0    -0.215400   185.534211 
72    gq   0.587190   0.139750 0 0 0    -0.011681 
              20.889300 0    -0.215400     185.534211 
73    pz     65.6000 
c 
c         PELVIS 
91    sq   125.1042   110.7756 0 0 0 0 -13858.4987  
       0    -3.7600 0 
92    sq   141.1344   124.8806 0 0 0 0 -17624.9521 0    -2.9700 0 
93    py    -2.9700 
94    py     4.9500 
95    pz    13.3100 
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c 
c         SPINE 
100      sq      6.1256     3.4782 0 0 0 0   -21.3063 0     5.4450 0 
105      sq      6.1256     3.4782 0 0 0 0   -21.3063 0     1.2250 0 
101      pz    20.9150 
102      pz    80.7300 
103      pz    33.3700 
c 
c     SKELETON  
c 
c 
c             SKULL (head) 
c 
c 
c             CRANIUM 
110    sq  3826.2328  2376.5040  4880.3218 0 0 0  
     -210658.6023 0 0    87.3000 
111    sq   2428.3114  1430.8517  3200.7476 0 0 0  
          -105456.9515 0 0    87.3000 
c 
c         FACIAL 
120      sq     80.1920    48.4416 0 0 0 0 -3884.6300 0 0 0 
121      sq     59.3670    32.6041 0 0 0 0 -1935.6084 0 0 0 
c 
122      pz    78.4950 
123      pz    88.9900 
c 
c         RIBS 
131      sq     94.0900   250.5889 0 0 0 0 -23577.9096 0 0 0 
132      sq     84.9162   235.4690 0 0 0 0 -19995.1407 0 0 0 
133      pz    63.9750 
134     pz    62.6450 
135     pz     61.3150 
136     pz     59.9850 
137     pz     58.6550 
138     pz     57.3250 
139     pz     55.9950 
74      pz     54.6650 
75      pz     53.3350 
76      pz     52.0050 
77      pz     50.6750 
78      pz     49.3450 
79      pz     48.0150 
80      pz     46.6850 
81      pz     45.3550 
82      pz     44.0250 
83      pz     42.6950 
84      pz     41.3650 
85      pz    40.0350 
86      pz    38.7050 
87      pz    37.3750 
88      pz    36.0450 
89      pz    34.7150 
98     pz    33.3850 
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c 
c         CLAVICLES 
140     tz    0     9.1600    64.8850 
           17.9650   0.757850   0.757850 
141     p   6.759700 1 0      9.160 
142     p   6.759700 -1 0     -9.160 
143     p   0.812760 1 0      9.160 
144     p   0.812760 -1 0     -9.160 
c 
c         SCAPULAE 
156     sq    94.0900   312.5824 0 0 0 0 -29410.8780  
           0 0 0  
150   p      0.2650 1 0 0 
151   p      0.2650 -1 0 0 
152   p      0.8550 1 0 0 
153   p      0.8550 -1 0 0 
154   pz    48.3900 
155   pz    63.9855 
c 
c         STOMACH 
210    sq   503.4100   792.9687   120.9208 0 0 0 -6947.6746 
              7.4500    -3.9600    33.2750 
211    sq   275.5292   478.6979    55.1380 0 0 0 -2696.7454 
              7.4500    -3.9600    33.2750 
c extent     3.7350    11.1650    -6.9200    -1.0000    25.6950    
40.8550 
c 
c         SMALL INTESTINE 
221    py    -4.8100 
222    py     2.1800 
223    pz    16.1600 
c 
c         ASCENDING COLON 
230    sq     6.1256     5.4289 0 0 0 0   -33.2554    -7.9150    -
2.3350 0 
233    sq     3.2247     2.7250 0 0 0 0    -8.7873    -7.9150    -
2.3350 0 
231    pz    13.7400 
232    pz    22.8150 
c 
c         TRANSVERSE COLON 
240    sq  0   2.030625     6.1256 0 0 0   -12.4388 0    -2.3350    
24.2450 
243    sq  0   0.839972     3.8671 0 0 0    -3.2483 0    -2.3350    
24.2450 
241    px     9.7800 
242    px    -9.7800 
c 
c 
c         DESCENDING COLON 
251     pz     8.2900 
250    gq   4.452100   3.062500     0.100054 0     1.043675    -
0.445302  
            -66.550119      -8.652063       1.853917   241.174590 
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252    gq   2.544025   1.525225     0.050647 0     0.519784    -
0.254455  
            -38.028159      -4.309010       1.167563   141.274707 
c 
c 
c         SIGMOID COLON 
282    px     2.7950 
280    ty     2.7950 0     8.2900     5.4400     1.6650     1.3750 
281    ty      2.795 0 0      2.850     1.6650     1.3750 
283    ty     2.7950 0     8.2900     5.4400     1.0400     0.7500 
284    ty      2.795 0 0      2.850     1.0400     0.7500 
c 
c         KIDNEYS 
310    sq    62.7811   499.8913    41.9467 0 0 0 -1147.3631 
              5.5900     5.9400    30.9000 
311    sq    62.7811   499.8913    41.9467 0 0 0 -1147.3631 
             -5.5900     5.9400    30.9000 
312    px     2.7400 
313    px    -2.7400 
c 
c         LIVER 
320    sq    62.7264   235.4690 0 0 0 0 -14770.1242 0 0 0 
321     p      1834.5      1359.5     -1492.3    -61006.0 
322    pz    40.8800 
c 
c 
c         LUNGS 
330    sq      26.0083      10.2495       1.0828 0 0 0 
               -537.2548     7.9150 0    41.3550 
331   sq      26.0083      10.2495       1.0828 0 0 0  
              -537.2548    -7.9150 0    41.3550 
333    px    -5.2000 
334    py     1.3500 
335    pz    43.8000 
336    pz    51.2500 
337    px     7.5000 
338    py     0.8500 
339    pz    52.0000 
c 
c         TESTICLES 
370    sq     6.7262422     5.082094     2.157961 0 0 0    -8.5887387 
              1.1300    -7.5500    -1.9950 
371    sq     6.7262422     5.082094     2.157961 0 0 0    -8.5887387 
             -1.1300    -7.5500    -1.9950 
c 
c         URINARY BLADDER 
410    sq   126.0679   229.5945   248.8590 0 0 0 -2683.8589 0 
             -4.0550     8.6050 
411    sq    93.5215   177.0773   193.1376 0 0 0 -1788.4246 0 
             -4.0550     8.6050 
c extent    -4.6140     4.6140    -7.8740    -1.0360     4.3210    
10.8890 
c 
c      PROSTATE 
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500    s    0 -6.0025 2.805 2.5 
c      Void 
600    so 301 
c 
c     STATISTICS 
c  Weight =    64.67 kg ( =   142.58 pounds) 
c  Height =   173.70 cm ( =    68.39 inches) 
  
c 
c         ESOPHAGUS 
tr6       0.000      2.432     40.190 
       0.722234  -0.621258  -0.303247 
       0.651955   0.757926   0.000000 
       0.229844  -0.197697       0.953 
c 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c      MATERIALS 
c      Compositions from ORNL Report TM-8381 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c      Adult Tissues (Density = 1.04 g/cc) 
m1       1001  -0.10454 
         6000  -0.22663 
         7014  -0.02490 
         8016  -0.63525 
        11023  -0.00112 
        12000  -0.00013 
        14000  -0.00030 
        15031  -0.00134 
        16000  -0.00204 
        17000  -0.00133 
        19000  -0.00208 
        20000  -0.00024 
        26000  -0.00005 
        30000  -0.00003 
        37085  -0.00001 
        40000  -0.00001 
c 
c       Skeleton (Density = 1.4 g/cc) 
m2       1001  -0.07337 
         6000  -0.25475 
         7014  -0.03057 
         8016  -0.47893 
         9019  -0.00025 
        11023  -0.00326 
        12000  -0.00112 
        14000  -0.00002 
        15031  -0.05095 
        16000  -0.00173 
        17000  -0.00143 
        19000  -0.00153 
        20000  -0.10190 
        26000  -0.00008 
        30000  -0.00005 
        37085  -0.00002 
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c       38084  -0.00003 
        82000  -0.00001 
c 
c       Lung (Density = 0.296 g/cc) 
m3       1001  -0.10134 
         6000  -0.10238 
         7014  -0.02866 
         8016  -0.75752 
        11023  -0.00184 
        12000  -0.00007 
        14000  -0.00006 
        15031  -0.00080 
        16000  -0.00225 
        17000  -0.00266 
        19000  -0.00194 
        20000  -0.00009 
        26000  -0.00037 
        30000  -0.00001 
        37085  -0.00001 
c 
c      Air (Density = 0.001020 /cc) 
m4       6000  -0.00012 
         7014  -0.75527 
         8016  -0.23178 
        18000  -0.01283 
c 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c   User Supplied Cards 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
mode p e 
nps 10000000 
sdef erg=.03549 par= 2 pos= 0 -6.0025 4.305 
     erg=.03549 par= 2 pos= 0 -5.5025 4.305 
     erg=.03549 par= 2 pos= 0 -5.0025 4.305 
     erg=.03549 par= 2 pos= 0 -4.5025 4.305 
     erg=.03549 par= 2 pos= -1 -6.0025 3.805 
     erg=.03549 par= 2 pos= -1 -5.5025 3.805 
     erg=.03549 par= 2 pos= -1 -4.5025 3.805 
     erg=.03549 par= 2 pos= -.5 -6.0025 3.805 
     erg=.03549 par= 2 pos= -.5 -5.5025 3.805 
     erg=.03549 par= 2 pos= -.5 -4.5025 3.805 
     erg=.03549 par= 2 pos= -.5 -3.0025 3.805 
     erg=.03549 par= 2 pos= -.5 -2.0025 3.805 
     erg=.03549 par= 2 pos= .5 -6.0025 3.805 
     erg=.03549 par= 2 pos= .5 -4.0025 3.805 
     erg=.03549 par= 2 pos= .5 -3.5025 3.805 
     erg=.03549 par= 2 pos= .5 -2.5025 3.805 
     erg=.03549 par= 2 pos= .5 -2.0025 3.805 
     erg=.03549 par= 2 pos= 1 -6.0025 3.805 
     erg=.03549 par= 2 pos= 1 -5.5025 3.805 
     erg=.03549 par= 2 pos= 1 -5.0025 3.805 
     erg=.03549 par= 2 pos= 1 -4.5025 3.805 
     erg=.03549 par= 2 pos= -1.5 -6.0025 3.305 
     erg=.03549 par= 2 pos= -1.5 -5.5025 3.305 
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     erg=.03549 par= 2 pos= -1.5 -5.0025 3.305 
     erg=.03549 par= 2 pos= -1.5 -4.5025 3.305 
     erg=.03549 par= 2 pos= -1.5 -4.0025 3.305 
     erg=.03549 par= 2 pos= -1 -3.5025 3.305 
     erg=.03549 par= 2 pos= -1 -2.5025 3.305 
     erg=.03549 par= 2 pos= -1 -2.0025 3.305 
     erg=.03549 par= 2 pos= 1 -3.5025 3.305 
     erg=.03549 par= 2 pos= 1 -3.0025 3.305 
     erg=.03549 par= 2 pos= 1 -2.5025 3.305 
     erg=.03549 par= 2 pos= 1 -2.0025 3.305 
     erg=.03549 par= 2 pos= 1.5 -6.0025 3.305 
     erg=.03549 par= 2 pos= 1.5 -5.5025 3.305 
     erg=.03549 par= 2 pos= 1.5 -5.0025 3.305 
     erg=.03549 par= 2 pos= 1.5 -4.5025 3.305 
     erg=.03549 par= 2 pos= 1.5 -4.0025 3.305 
     erg=.03549 par= 2 pos= -2 -5.0025 2.805 
     erg=.03549 par= 2 pos= -2 -4.5025 2.805 
     erg=.03549 par= 2 pos= -1.5 -6.0025 2.805 
     erg=.03549 par= 2 pos= -1.5 -5.5025 2.805 
     erg=.03549 par= 2 pos= -1.5 -3.5025 2.805 
     erg=.03549 par= 2 pos= -1.5 -3.0025 2.805 
     erg=.03549 par= 2 pos= 2 -6.0025 2.805 
     erg=.03549 par= 2 pos= 2 -5.0025 2.805 
     erg=.03549 par= 2 pos= -2 -5.0025 2.305 
     erg=.03549 par= 2 pos= -2 -4.5025 2.305 
     erg=.03549 par= 2 pos= -2 -3.5025 2.305 
     erg=.03549 par= 2 pos= -2 -3.0025 2.305 
     erg=.03549 par= 2 pos= -1 -6.0025 2.305 
     erg=.03549 par= 2 pos= -1 -2.5025 2.305 
     erg=.03549 par= 2 pos= -1 -2.0025 2.305 
     erg=.03549 par= 2 pos= 1 -3.5025 2.305 
     erg=.03549 par= 2 pos= 1 -2.5025 2.305 
     erg=.03549 par= 2 pos= 1 -2.0025 2.305 
     erg=.03549 par= 2 pos= 2 -5.0025 2.305 
     erg=.03549 par= 2 pos= 2 -4.5025 2.305 
     erg=.03549 par= 2 pos= 2 -4.0025 2.305 
     erg=.03549 par= 2 pos= 2 -3.5025 2.305 
     erg=.03549 par= 2 pos= 2 -3.0025 2.305 
     erg=.03549 par= 2 pos= -2.5 -4.0025 1.805 
     erg=.03549 par= 2 pos= -2.5 -3.5025 1.805 
     erg=.03549 par= 2 pos= -1.5 -5.5025 1.805 
     erg=.03549 par= 2 pos= -1.5 -5.0025 1.805 
     erg=.03549 par= 2 pos= -1.5 -4.5025 1.805 
     erg=.03549 par= 2 pos= -1.5 -3.0025 1.805 
     erg=.03549 par= 2 pos= -1.5 -2.5025 1.805 
     erg=.03549 par= 2 pos= -.5 -6.0025 1.805 
     erg=.03549 par= 2 pos= -.5 -5.0025 1.805 
     erg=.03549 par= 2 pos= -.5 -4.0025 1.805 
     erg=.03549 par= 2 pos= -.5 -2.5025 1.805 
     erg=.03549 par= 2 pos= -.5 -2.0025 1.805 
     erg=.03549 par= 2 pos= .5 -6.0025 1.805 
     erg=.03549 par= 2 pos= .5 -5.5025 1.805 
     erg=.03549 par= 2 pos= .5 -5.0025 1.805 
     erg=.03549 par= 2 pos= .5 -4.5025 1.805 
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     erg=.03549 par= 2 pos= .5 -3.0025 1.805 
     erg=.03549 par= 2 pos= .5 -2.5025 1.805 
     erg=.03549 par= 2 pos= .5 -2.0025 1.805 
     erg=.03549 par= 2 pos= 1.5 -6.0025 1.805 
     erg=.03549 par= 2 pos= 1.5 -5.5025 1.805 
     erg=.03549 par= 2 pos= 1.5 -4.5025 1.805 
     erg=.03549 par= 2 pos= 1.5 -3.0025 1.805 
     erg=.03549 par= 2 pos= 1.5 -2.5025 1.805 
     erg=.03549 par= 2 pos= -2.5 -4.5025 1.305 
     erg=.03549 par= 2 pos= -2.5 -4.0025 1.305 
     erg=.03549 par= 2 pos= -2 -5.0025 1.305 
     erg=.03549 par= 2 pos= -2 -3.5025 1.305 
     erg=.03549 par= 2 pos= -2 -3.0025 1.305 
     erg=.03549 par= 2 pos= -2 -2.5025 1.305 
     erg=.03549 par= 2 pos= 1.5 -5.0025 1.305 
     erg=.03549 par= 2 pos= 1.5 -4.0025 1.305 
     erg=.03549 par= 2 pos= 2 -5.0025 1.305 
     erg=.03549 par= 2 pos= 2 -4.5025 1.305 
     erg=.03549 par= 2 pos= 2 -4.0025 1.305 
     erg=.03549 par= 2 pos= 2 -3.5025 1.305 
     erg=.03549 par= 2 pos= 2 -3.0025 1.305 
*f18:p,e 1 
*f38:p,e 3 
*f48:p,e 4 
*f58:p,e 5 
*f68:p,e 6 
*f88:p,e 8 
*f148:p,e 14 
*f168:p,e 16 
*f178:p,e 17 
*f198:p,e 19 
*f218:p,e 21 
*f238:p,e 23 
*f258:p,e 25 
*f268:p,e 26 
*f278:p,e 27 
*f288:p,e 28 
*f298:p,e 29 
*f318:p,e 31 
*f358:p,e 35 
*f368:p,e 36 
*f378:p,e 37 
*f478:p,e 47 
*f708:p,e 70   
prdmp 2j -1 2j 
print -130 -140 
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103Pd INPUT FILE 
 
Male Phantom at  18.0 Years 
c +++++++++++++++++++++++++++++++++++++++++ 
c 
c    File Prepared by Body Builder 
c    CopyRight 1996-1998, White Rock Science 
c 
c    This input file is for the use of 
c    BodyBuilder License holder only. 
c    Distribution is Prohibited. 
c 
c +++++++++++++++++++++++++++++++++++++++++ 
c 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c           CELLS 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c SkeletonVolume = 6366.150000, skel_vol = 6303.571429 
c 
c         LEG BONES 
1      2 -1.40    -4 53 (-51:-52) 
                 vol=  2450.00 imp:p,e = 1 
c 
c         ARM BONES 
2     2 -1.40     4 -73 (-71:-72) 
                 vol=   843.50 imp:p,e = 1 
c 
c         PELVIS 
3     2 -1.40     91 -92 93 4 -101 (95:-94) 
                 vol=   533.00 imp:p,e = 1 
c 
c         SPINE 
4    2 -1.40   -100 -103 101 vol= 434.2500 imp:p,e = 1 
5    2 -1.40   -100 -8   103 vol= 325.6875 imp:p,e = 1 
6    2 -1.40   -105 -102 8   vol= 108.5625 imp:p,e = 1 
c               Total Spine vol=   868.50 
c 
c         SKULL & FACE 
7    2 -1.40   (111 -110):(121 -120 122 -1 -123 110)  
                 vol=   832.50 imp:p,e = 1 
c 
c         RIBS 
8    2 -1.40    132 -131 ((134 -133):(136 -135):(138 -137):(74 -139): 
                 (76 -75):(78 -77):(80 -79):(82 -81):(84 -83): 
                 (86 -85):(88 -87):(98 -89)) 
                 vol=   612.50 imp:p,e = 1 
c 
c         CLAVICLES 
9    2 -1.40    -140 ((141 -143):(-142 144)) 
                 vol=    48.15 imp:p,e = 1 
c 
c         SCAPULAE 
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10    2 -1.40     131 -156 154 -155 ((150 -152):(-151 153)) 
                 vol=   178.00 imp:p,e = 1 
c 
c         BRAIN 
11     1 -1.04    -111 
                 vol=  1360.00 imp:p,e = 1 
c 
c 
c         STOMACH  Wall 
14   1 -1.04       -210 211 
                 vol=   132.50 imp:p,e = 1 
c                  Contents 
15   1 -1.04       -211 
                 vol=   218.50 imp:p,e = 1 
c 
c         SMALL INTESTINE 
16   1 -1.04       -91 221 -222 223 -7 
C                exclude         Ascending Colon     
                        (232:230:-223) 
c                exclude         Transverse Colon     
                        (240 :241 :-242 ) 
c                exclude         Descending Colon     
                        (232:250:-223) 
                  vol=   933.00 imp:p,e = 1 
c 
c         ASCENDING COLON  Wall 
17   1 -1.04       -230 233 231 -232 
                  vol=    80.35 imp:p,e = 1 
c                          Contents 
18   1 -1.04       -233 231 -232 
                  vol=    84.85 imp:p,e = 1 
c 
c         TRANSVERSE COLON  Wall 
19   1 -1.04       -240 243 -241 242 
            vol=   106.65 imp:p,e = 1 
c                           Contents 
20   1 -1.04       -243 -241 242 
            vol=   111.50 imp:p,e = 1 
c 
c         DESCENDING COLON  Wall 
21   1 -1.04       -250 252 251 -232 
             vol=   79.10 imp:p,e = 1 
c                            Contents 
22   1 -1.04       -252 251 -232 
             vol=   90.10 imp:p,e = 1 
c 
c         SIGMOID COLON  Wall 
23   1 -1.04       (-280 282 -251):(-281 -282 4) 
             vol=   62.10 imp:p,e = 1 
c 
c         KIDNEYS 
25     1 -1.04     (-310 312):(-311 -313) 
                  vol=   263.00 imp:p,e = 1 
c 
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c         LIVER 
26     1 -1.04     -320 -321 7 -322 -132 
                   vol=  1590.00 imp:p,e = 1 
c 
c         LUNGS 
27     3 -0.296   332 ((-331 (-335:336:334:-333)): 
                        (-330 ( 339:338:337))) 
                 vol=  2790.00 imp:p,e = 1 
c 
c         TESTICLES 
28   1 -1.04       -370:-371 
             vol=   26.30 imp:p,e = 1 
c 
c         URINARY BLADDER  Wall 
29   1 -1.04       -410 411 
             vol=   40.10 imp:p,e = 1 
c                          Contents 
30   1 -1.04       -411 
             vol=  178.50 imp:p,e = 1 
c 
c         PENIS & SCROTUM 
31     1 -1.04       -1 -4 47 -45 49 -48 37 38 
c                exclude         Testicles 
                  370 371 
             vol=  126.20 imp:p,e = 1 
c 
c         SKIN 
c 
c              Head & Neck Skin 
32    1 -1.04       ((-21 22 9):(-20 23 -9 12)) 
                   imp:p,e = 1 
33    1 -1.04       28 -27 8 -12 
             vol=  284.50 imp:p,e = 1 
c            (Above Volume for Head + Neck Skin Combined 
c 
c           Trunk Skin 
34    1 -1.04       (-8 18 20 -10) 
                   : (4 -18 -10 11 
                  ) 
             vol= 1220.00 imp:p,e = 1 
c 
c         Penis & Scrotum Skin 
35     1 -1.04       -1 -4  41 -42 43 -44 31 32 #31 
c                exclude         Testicles 
                  370 371 
             vol=   18.45 imp:p,e = 1 
c        Legs Skin 
36    1 -1.04      (-4 34 -31 36 32):(-31 33 -36 32) 
             vol=  522.25 imp:p,e = 1 
37    1 -1.04      (-4 35 -32 36 31):(-32 33 -36 31) 
             vol=  522.25 imp:p,e = 1 
c 
c            HEAD 
c 
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38    1 -1.04       ((-22 9):(-23 -9 12)) 
c                exclude         Skull 
                        110 
c                exclude         Face Bones 
                        (-121:120:-122:1:123:-110) 
c                exclude         Spine 
                        (105:-8:102) 
                 imp:p,e = 1 
c 
c            NECK 
c 
39    1 -1.04       -28 8 -12 
c                exclude         Spine 
                         105 
                 imp:p,e = 1 
c 
c         OUTER TRUNK---ARMS & SCAPULAE 
c 
40    1 -1.04       4 131 -18 -11 
c                exclude         Scapulae 
                        (-131:156:-150:152:-154:155) 
                        (-131:156:151:-153:-154:155) 
c                exclude         Arm Bones 
                        (-4:71:73) (-4:72:73) 
                 imp:p,e = 1 
c 
c         UPPER TRUNK---ABOVE RIBS 
c 
41    1 -1.04   ((-18 -131 133) : (-8 18 -20 -10)) 
c                exclude         Spine 
                       (105:102:-8)(100:8:-133) 
c                exclude         Clavicles 
                       (140:-141:143) (140:142:-144) 
c                exclude         Upper Lungs 
                        (-133:330) (-133:331) 
                 imp:p,e = 1 
c 
c 
c         UPPER RIB CAGE 
c 
42    1 -1.04       -131 132 79 -133 
c                exclude         Ribs 1-9 
                  (131:-132:133:-134) (131:-132:135:-136) (131:-
132:137:-138) 
                  (131:-132:139:-74) (131:-132:75:-76) (131:-132:77:-
78) 
                 imp:p,e = 1 
c 
c 
c         LOWER RIB CAGE 
c 
43    1 -1.04       -131 132 -79 98 
c                exclude         Ribs 10-12 
                  (131:-132:85:-86) (131:-132:87:-88) (131:-132:89:-98) 
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                  (131:-132:79:-80) (131:-132:81:-82) (131:-132:83:-84) 
                 imp:p,e = 1 
c 
c 
c         HIGH CHEST ORGANS 
c 
44    1 -1.04       -132 -133 332 
c                exclude          Spine 
                        (100:133:-332) 
c                exclude          Lungs 
                        (330:133:-332:(-339 -338 -337)) 
                        (331:133:-332:(335 -336 -334 333)) 
                 imp:p,e = 1 
c 
c         CHEST---LIVER LEVEL 
c 
45    1 -1.04       ((-132 -332 98):(-131 -98 7)) 
c                exclude          Spine 
                        (100:332:-7) 
c                exclude          Kidneys 
                        (310:-312) (311:313) 
c                exclude          Liver 
                        #26 
c                       (320:321:322:-7) 
c                exclude         Stomach 
                       210 
                 imp:p,e = 1 
c 
c 
c         LOWER TRUNK 
c  
46    1 -1.04       -131 4 -7 
c                exclude           Spine  
                        (100:-101:7) 
c                exclude           Pelvis 
                        #3 
c                exclude           Small Intestine 
                        (91:-221:222:-223:7) 
c                exclude           Ascending Colon 
                        (232:230:-231) 
c                exclude           Descending Colon 
                        (232:250:-251) 
c                exclude           Sigmoid Colon 
                        (280:-282:251) (281:282:-4) 
c                exclude           Urinary Bladder 
                        410 
c                exclude           Prostate 
                        500 
                 imp:p,e = 1 
                 imp:p,e = 1 
c 
c        LEGS 
c 
47    1 -1.04       -4 (-34:-35) 36 
 66
c                exclude           Leg Bones 
                        (4:51:-53) (4:52:-53) 
             vol= 14605.50 imp:p,e = 1 
c 
c         SURROUNDING AIR 
48    4 -0.001293   -600 
c            exclude         HEAD & NECK 
                       (21:-9)  (20:9:-8) 
c            exclude         TRUNK 
                        (-4:10:8) 
c            exclude         LEGS 
                        (4:-33:(31 32)) 
c                exclude         GENITALIA 
                    (1:4:-41:42:-43:44:-31:-32) 
             imp:p,e = 1 
c            air            OUTSIDE of NECK 
49    4 -0.001293   -20 27 8 -12 
             imp:p,e = 1 
c 
c         PROSTATE 
70    1 -1.04  -500 vol= 16.3625 imp:p,e = 1 
c 
c         VOID 
50   0               600 
             imp:p,e = 0 
  
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c           SURFACES 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c Planes used in several places 
c 
1     py 0 
4     pz 0 
332   pz    41.3550 
7     pz    25.6700 
8     pz    66.5500 
9     pz    87.3000 
12    pz    74.6000 
c 
c         BODY SURFACE 
c 
c             HEAD 
21    sq  5280.8272  3394.8568  6597.4275 0 0 0 -343913.3409 0 0     
87.300 
22    sq  4831.0562  3077.0291  6069.0021 0 0 0 -300362.3462 0 0     
87.300 
20    sq   101.3042    65.1249 0 0 0 0 -6597.427523 0 0 0 
23    sq    97.6144    62.1732 0 0 0 0 -6069.002054 0 0 0 
c 
c 
c             NECK 
27    cz     5.4850 
28    cz     5.3000 
c 
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c 
c             TORSO 
10    sq   101.7072   353.8161 0 0 0 0 -35985.653691 0 0 0 
11    sq    98.0100   346.8906 0 0 0 0 -33998.750156 0 0 0 
18    pz    66.3650 
c 
c             LEGS 
c      left 
31    gq 1 1 0 0 0  -0.1862   -18.8100 0 0 0 
32    gq 1 1 0 0 0   0.1862    18.8100 0 0 0 
33    pz  -79.185 
34    gq 1 1 0 0 0  -0.1862   -18.6250 0 0 0 
35    gq 1 1 0 0 0   0.1862    18.6250 0 0 0 
36    pz  -79.000 
37    gq 1 1 0 0 0  -0.1862   -18.9950 0 0 0 
38    gq 1 1 0 0 0   0.1862    18.9950 0 0 0 
c 
c         PENIS & SCROTUM 
41    pz    -4.1750 
42    p  0 -10.74 -1 100.00 
43    p   -10.74 0 1 -100.00 
44    p    -10.74 0 -1 100.00 
47    pz    -3.9900 
45    p  0 -10.85 -1 100.00 
49    p   -10.85 0 1 -100.00 
48    p    -10.85 0 -1 100.00 
c 
c     SKELETON  
c 
c 
c         LEG BONES 
51    gq   1 1  0.007875 0 0  -0.186687   -18.625000 
            0   1.549817      76.0991 
52    gq   1 1  0.007875 0 0   0.186687    18.625000 
            0   1.549817      76.0991 
53    pz   -78.8150 
c 
c         ARM BONES ( left/right) ) 
71     gq   0.587190     0.139750 0 0 0     0.011681 
             -20.889300 0    -0.215400   185.534211 
72    gq   0.587190   0.139750 0 0 0    -0.011681 
              20.889300 0    -0.215400     185.534211 
73    pz     65.6000 
c 
c         PELVIS 
91    sq   125.1042   110.7756 0 0 0 0 -13858.4987  
       0    -3.7600 0 
92    sq   141.1344   124.8806 0 0 0 0 -17624.9521 0    -2.9700 0 
93    py    -2.9700 
94    py     4.9500 
95    pz    13.3100 
c 
c         SPINE 
100      sq      6.1256     3.4782 0 0 0 0   -21.3063 0     5.4450 0 
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105      sq      6.1256     3.4782 0 0 0 0   -21.3063 0     1.2250 0 
101      pz    20.9150 
102      pz    80.7300 
103      pz    33.3700 
c 
c     SKELETON  
c 
c 
c             SKULL (head) 
c 
c 
c             CRANIUM 
110    sq  3826.2328  2376.5040  4880.3218 0 0 0  
     -210658.6023 0 0    87.3000 
111    sq   2428.3114  1430.8517  3200.7476 0 0 0  
          -105456.9515 0 0    87.3000 
c 
c         FACIAL 
120      sq     80.1920    48.4416 0 0 0 0 -3884.6300 0 0 0 
121      sq     59.3670    32.6041 0 0 0 0 -1935.6084 0 0 0 
c 
122      pz    78.4950 
123      pz    88.9900 
c 
c         RIBS 
131      sq     94.0900   250.5889 0 0 0 0 -23577.9096 0 0 0 
132      sq     84.9162   235.4690 0 0 0 0 -19995.1407 0 0 0 
133      pz    63.9750 
134     pz    62.6450 
135     pz     61.3150 
136     pz     59.9850 
137     pz     58.6550 
138     pz     57.3250 
139     pz     55.9950 
74      pz     54.6650 
75      pz     53.3350 
76      pz     52.0050 
77      pz     50.6750 
78      pz     49.3450 
79      pz     48.0150 
80      pz     46.6850 
81      pz     45.3550 
82      pz     44.0250 
83      pz     42.6950 
84      pz     41.3650 
85      pz    40.0350 
86      pz    38.7050 
87      pz    37.3750 
88      pz    36.0450 
89      pz    34.7150 
98     pz    33.3850 
c 
c         CLAVICLES 
140     tz    0     9.1600    64.8850 
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           17.9650   0.757850   0.757850 
141     p   6.759700 1 0      9.160 
142     p   6.759700 -1 0     -9.160 
143     p   0.812760 1 0      9.160 
144     p   0.812760 -1 0     -9.160 
c 
c         SCAPULAE 
156     sq    94.0900   312.5824 0 0 0 0 -29410.8780  
           0 0 0  
150   p      0.2650 1 0 0 
151   p      0.2650 -1 0 0 
152   p      0.8550 1 0 0 
153   p      0.8550 -1 0 0 
154   pz    48.3900 
155   pz    63.9855 
c 
c         STOMACH 
210    sq   503.4100   792.9687   120.9208 0 0 0 -6947.6746 
              7.4500    -3.9600    33.2750 
211    sq   275.5292   478.6979    55.1380 0 0 0 -2696.7454 
              7.4500    -3.9600    33.2750 
c extent     3.7350    11.1650    -6.9200    -1.0000    25.6950    
40.8550 
c 
c         SMALL INTESTINE 
221    py    -4.8100 
222    py     2.1800 
223    pz    16.1600 
c 
c         ASCENDING COLON 
230    sq     6.1256     5.4289 0 0 0 0   -33.2554    -7.9150    -
2.3350 0 
233    sq     3.2247     2.7250 0 0 0 0    -8.7873    -7.9150    -
2.3350 0 
231    pz    13.7400 
232    pz    22.8150 
c 
c         TRANSVERSE COLON 
240    sq  0   2.030625     6.1256 0 0 0   -12.4388 0    -2.3350    
24.2450 
243    sq  0   0.839972     3.8671 0 0 0    -3.2483 0    -2.3350    
24.2450 
241    px     9.7800 
242    px    -9.7800 
c 
c 
c         DESCENDING COLON 
251     pz     8.2900 
250    gq   4.452100   3.062500     0.100054 0     1.043675    -
0.445302  
            -66.550119      -8.652063       1.853917   241.174590 
252    gq   2.544025   1.525225     0.050647 0     0.519784    -
0.254455  
            -38.028159      -4.309010       1.167563   141.274707 
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c 
c 
c         SIGMOID COLON 
282    px     2.7950 
280    ty     2.7950 0     8.2900     5.4400     1.6650     1.3750 
281    ty      2.795 0 0      2.850     1.6650     1.3750 
283    ty     2.7950 0     8.2900     5.4400     1.0400     0.7500 
284    ty      2.795 0 0      2.850     1.0400     0.7500 
c 
c         KIDNEYS 
310    sq    62.7811   499.8913    41.9467 0 0 0 -1147.3631 
              5.5900     5.9400    30.9000 
311    sq    62.7811   499.8913    41.9467 0 0 0 -1147.3631 
             -5.5900     5.9400    30.9000 
312    px     2.7400 
313    px    -2.7400 
c 
c         LIVER 
320    sq    62.7264   235.4690 0 0 0 0 -14770.1242 0 0 0 
321     p      1834.5      1359.5     -1492.3    -61006.0 
322    pz    40.8800 
c 
c 
c         LUNGS 
330    sq      26.0083      10.2495       1.0828 0 0 0 
               -537.2548     7.9150 0    41.3550 
331   sq      26.0083      10.2495       1.0828 0 0 0  
              -537.2548    -7.9150 0    41.3550 
333    px    -5.2000 
334    py     1.3500 
335    pz    43.8000 
336    pz    51.2500 
337    px     7.5000 
338    py     0.8500 
339    pz    52.0000 
c 
c         TESTICLES 
370    sq     6.7262422     5.082094     2.157961 0 0 0    -8.5887387 
              1.1300    -7.5500    -1.9950 
371    sq     6.7262422     5.082094     2.157961 0 0 0    -8.5887387 
             -1.1300    -7.5500    -1.9950 
c 
c         URINARY BLADDER 
410    sq   126.0679   229.5945   248.8590 0 0 0 -2683.8589 0 
             -4.0550     8.6050 
411    sq    93.5215   177.0773   193.1376 0 0 0 -1788.4246 0 
             -4.0550     8.6050 
c extent    -4.6140     4.6140    -7.8740    -1.0360     4.3210    
10.8890 
c 
c      PROSTATE 
500    s    0 -6.0025 2.805 2.5 
c      Void 
600    so 301 
 71
c 
c     STATISTICS 
c  Weight =    64.67 kg ( =   142.58 pounds) 
c  Height =   173.70 cm ( =    68.39 inches) 
  
c 
c         ESOPHAGUS 
tr6       0.000      2.432     40.190 
       0.722234  -0.621258  -0.303247 
       0.651955   0.757926   0.000000 
       0.229844  -0.197697       0.953 
c 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c      MATERIALS 
c      Compositions from ORNL Report TM-8381 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c      Adult Tissues (Density = 1.04 g/cc) 
m1       1001  -0.10454 
         6000  -0.22663 
         7014  -0.02490 
         8016  -0.63525 
        11023  -0.00112 
        12000  -0.00013 
        14000  -0.00030 
        15031  -0.00134 
        16000  -0.00204 
        17000  -0.00133 
        19000  -0.00208 
        20000  -0.00024 
        26000  -0.00005 
        30000  -0.00003 
        37085  -0.00001 
        40000  -0.00001 
c 
c       Skeleton (Density = 1.4 g/cc) 
m2       1001  -0.07337 
         6000  -0.25475 
         7014  -0.03057 
         8016  -0.47893 
         9019  -0.00025 
        11023  -0.00326 
        12000  -0.00112 
        14000  -0.00002 
        15031  -0.05095 
        16000  -0.00173 
        17000  -0.00143 
        19000  -0.00153 
        20000  -0.10190 
        26000  -0.00008 
        30000  -0.00005 
        37085  -0.00002 
c       38084  -0.00003 
        82000  -0.00001 
c 
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c       Lung (Density = 0.296 g/cc) 
m3       1001  -0.10134 
         6000  -0.10238 
         7014  -0.02866 
         8016  -0.75752 
        11023  -0.00184 
        12000  -0.00007 
        14000  -0.00006 
        15031  -0.00080 
        16000  -0.00225 
        17000  -0.00266 
        19000  -0.00194 
        20000  -0.00009 
        26000  -0.00037 
        30000  -0.00001 
        37085  -0.00001 
c 
c      Air (Density = 0.001020 /cc) 
m4       6000  -0.00012 
         7014  -0.75527 
         8016  -0.23178 
        18000  -0.01283 
c 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
c   User Supplied Cards 
c ++++++++++++++++++++++++++++++++++++++++++++++ 
mode p e 
nps 10000000 
sdef erg=.021 par= 2 pos= 0 -6.0025 4.305 
     erg=.021 par= 2 pos= 0 -5.5025 4.305 
     erg=.021 par= 2 pos= -1 -6.0025 3.805 
     erg=.021 par= 2 pos= -1 -5.5025 3.805 
     erg=.021 par= 2 pos= -.5 -6.0025 3.805 
     erg=.021 par= 2 pos= -.5 -5.0025 3.805 
     erg=.021 par= 2 pos= -.5 -4.5025 3.805 
     erg=.021 par= 2 pos= -.5 -2.5025 3.805 
     erg=.021 par= 2 pos= -.5 -2.0025 3.805 
     erg=.021 par= 2 pos= -.5 -1.5025 3.805 
     erg=.021 par= 2 pos= .5 -6.0025 3.805 
     erg=.021 par= 2 pos= .5 -5.5025 3.805 
     erg=.021 par= 2 pos= .5 -5.0025 3.805 
     erg=.021 par= 2 pos= .5 -4.5025 3.805 
     erg=.021 par= 2 pos= .5 -2.5025 3.805 
     erg=.021 par= 2 pos= .5 -2.0025 3.805 
     erg=.021 par= 2 pos= .5 -1.5025 3.805 
     erg=.021 par= 2 pos= 1.5 -6.0025 3.805 
     erg=.021 par= 2 pos= 1.5 -5.0025 3.805 
     erg=.021 par= 2 pos= 1.5 -4.5025 3.805 
     erg=.021 par= 2 pos= -1.5 -6.0025 3.305 
     erg=.021 par= 2 pos= -1.5 -5.0025 3.305 
     erg=.021 par= 2 pos= -1.5 -4.5025 3.305 
     erg=.021 par= 2 pos= -1 -6.0025 3.305 
     erg=.021 par= 2 pos= -1 -4.0025 3.305 
     erg=.021 par= 2 pos= -1 -3.5025 3.305 
 73
     erg=.021 par= 2 pos= -1 -3.0025 3.305 
     erg=.021 par= 2 pos= -1 -1.5025 3.305 
     erg=.021 par= 2 pos= 1 -6.0025 3.305 
     erg=.021 par= 2 pos= 1 -4.5025 3.305 
     erg=.021 par= 2 pos= 1 -3.5025 3.305 
     erg=.021 par= 2 pos= 1 -3.0025 3.305 
     erg=.021 par= 2 pos= 1 -1.5025 3.305 
     erg=.021 par= 2 pos= 2 -6.0025 3.305 
     erg=.021 par= 2 pos= 2 -5.0025 3.305 
     erg=.021 par= 2 pos= 2 -4.5025 3.305 
     erg=.021 par= 2 pos= 2 -2.5025 3.305 
     erg=.021 par= 2 pos= -2 -5.5025 2.805 
     erg=.021 par= 2 pos= -2 -4.5025 2.805 
     erg=.021 par= 2 pos= -2 -4.0025 2.805 
     erg=.021 par= 2 pos= -1.5 -6.0025 2.805 
     erg=.021 par= 2 pos= -1.5 -2.5025 2.805 
     erg=.021 par= 2 pos= -1.5 -3.0025 2.805 
     erg=.021 par= 2 pos= -1 -2.0025 2.805 
     erg=.021 par= 2 pos= -1 -1.5025 2.805 
     erg=.021 par= 2 pos= 1 -6.0025 2.805 
     erg=.021 par= 2 pos= 1 -2.0025 2.805 
     erg=.021 par= 2 pos= 1 -1.5025 2.805 
     erg=.021 par= 2 pos= 1.5 -6.0025 2.805 
     erg=.021 par= 2 pos= 1.5 -4.0025 2.805 
     erg=.021 par= 2 pos= 1.5 -2.5025 2.805 
     erg=.021 par= 2 pos= 2.5 -5.0025 2.805 
     erg=.021 par= 2 pos= 2.5 -4.5025 2.805 
     erg=.021 par= 2 pos= -2 -5.5025 2.305 
     erg=.021 par= 2 pos= -2 -4.5025 2.305 
     erg=.021 par= 2 pos= -2 -3.0025 2.305 
     erg=.021 par= 2 pos= -2 -2.5025 2.305 
     erg=.021 par= 2 pos= -1 -6.0025 2.305 
     erg=.021 par= 2 pos= -1 -5.5025 2.305 
     erg=.021 par= 2 pos= -1 -2.0025 2.305 
     erg=.021 par= 2 pos= -1 -1.5025 2.305 
     erg=.021 par= 2 pos= 1 -6.0025 2.305 
     erg=.021 par= 2 pos= 1 -2.0025 2.305 
     erg=.021 par= 2 pos= 1 -1.5025 2.305 
     erg=.021 par= 2 pos= 2 -6.0025 2.305 
     erg=.021 par= 2 pos= 2 -5.5025 2.305 
     erg=.021 par= 2 pos= 2 -4.0025 2.305 
     erg=.021 par= 2 pos= 2 -3.5025 2.305 
     erg=.021 par= 2 pos= 2 -2.5025 2.305 
     erg=.021 par= 2 pos= -2.5 -4.5025 1.805 
     erg=.021 par= 2 pos= -2.5 -4.0025 1.805 
     erg=.021 par= 2 pos= -2.5 -3.5025 1.805 
     erg=.021 par= 2 pos= -1.5 -5.5025 1.805 
     erg=.021 par= 2 pos= -1.5 -4.5025 1.805 
     erg=.021 par= 2 pos= -1.5 -4.0025 1.805 
     erg=.021 par= 2 pos= -1.5 -2.5025 1.805 
     erg=.021 par= 2 pos= -1.5 -2.0025 1.805 
     erg=.021 par= 2 pos= -.5 -6.0025 1.805 
     erg=.021 par= 2 pos= -.5 -5.5025 1.805 
     erg=.021 par= 2 pos= -.5 -5.0025 1.805 
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     erg=.021 par= 2 pos= -.5 -4.0025 1.805 
     erg=.021 par= 2 pos= -.5 -3.0025 1.805 
     erg=.021 par= 2 pos= -.5 -2.5025 1.805 
     erg=.021 par= 2 pos= -.5 -2.0025 1.805 
     erg=.021 par= 2 pos= -.5 -1.5025 1.805 
     erg=.021 par= 2 pos= .5 -6.0025 1.805 
     erg=.021 par= 2 pos= .5 -5.0025 1.805 
     erg=.021 par= 2 pos= .5 -4.5025 1.805 
     erg=.021 par= 2 pos= .5 -3.5025 1.805 
     erg=.021 par= 2 pos= .5 -3.0025 1.805 
     erg=.021 par= 2 pos= .5 -2.0025 1.805 
     erg=.021 par= 2 pos= .5 -1.5025 1.805 
     erg=.021 par= 2 pos= 1.5 -5.5025 1.805 
     erg=.021 par= 2 pos= 1.5 -5.0025 1.805 
     erg=.021 par= 2 pos= 1.5 -4.5025 1.805 
     erg=.021 par= 2 pos= 1.5 -4.0025 1.805 
     erg=.021 par= 2 pos= 1.5 -3.5025 1.805 
     erg=.021 par= 2 pos= 1.5 -3.0025 1.805 
     erg=.021 par= 2 pos= 1.5 -2.5025 1.805 
     erg=.021 par= 2 pos= 1.5 -2.0025 1.805 
     erg=.021 par= 2 pos= 2.5 -5.0025 1.805 
     erg=.021 par= 2 pos= 2.5 -4.5025 1.805 
     erg=.021 par= 2 pos= 2.5 -3.5025 1.805 
     erg=.021 par= 2 pos= 2.5 -2.5025 1.805 
     erg=.021 par= 2 pos= -2.5 -4.0025 1.305 
     erg=.021 par= 2 pos= -2.5 -3.5025 1.305 
     erg=.021 par= 2 pos= -2 -5.0025 1.305 
     erg=.021 par= 2 pos= -2 -4.0025 1.305 
     erg=.021 par= 2 pos= -2 -3.0025 1.305 
     erg=.021 par= 2 pos= -2 -2.5025 1.305 
     erg=.021 par= 2 pos= 2 -5.5025 1.305 
     erg=.021 par= 2 pos= 2 -4.0025 1.305 
     erg=.021 par= 2 pos= 2 -3.0025 1.305 
     erg=.021 par= 2 pos= 2.5 -5.0025 1.305 
     erg=.021 par= 2 pos= 2.5 -3.5025 1.305 
*f18:p,e 1 
*f38:p,e 3 
*f48:p,e 4 
*f58:p,e 5 
*f68:p,e 6 
*f88:p,e 8 
*f148:p,e 14 
*f168:p,e 16 
*f178:p,e 17 
*f198:p,e 19 
*f218:p,e 21 
*f238:p,e 23 
*f258:p,e 25 
*f268:p,e 26 
*f278:p,e 27 
*f288:p,e 28 
*f298:p,e 29 
*f318:p,e 31 
*f358:p,e 35 
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*f368:p,e 36 
*f378:p,e 37 
*f478:p,e 47 
*f708:p,e 70   
prdmp 2j -1 2j 
print -130 –140 
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